Lamontagne, François

Professeur, Faculté de médecine et des sciences de la santé
FMSS Département de médecine

Coordonnées

Courriel


819-821-8000, poste 74977

Diplômes

(2010) Maîtrise avec mémoire (Maîtrise ès sciences - Maîtrise). McMaster University.

(2010) Postdoctorat (Clinician Investigator Program - professionnels de la santé). McMaster University.

(2008) Postdoctorat (Fellow of the Royal College of Physicians and Surgeons of Canada - professionnels de la santé). McMaster University.

(2006) Maîtrise avec mémoire (Maîtrise ès sciences - Maîtrise). Université de Sherbrooke.

(2006) Postdoctorat (Certificat de spécialité, CMQ (Collège des médecins du Québec) - professionnels de la santé). Université de Sherbrooke.

(2000) Doctorat (Doctorat en médecine - M.D.). Université de Montréal.

Titres de compétence

Certificat de médecine spécialisée en soins intensifs - Specialist Critical care medicine certificate. Collège Royal des Médecins et Chirurgiens du Canada.

Certificat de médecine spécialisée en soins intensifs - Specialist Critical care medicine certificate. Collège des médecins du Québec.

Certificat de spécialiste - Médecine interne générale - Specialist certificate - General Internal Medicine. Collège des médecins du Québec.

Certificat de spécialiste en médecine interne - Specialist internal medicine certificate. Collège Royal des Médecins et Chirurgiens du Canada.

Certificat du programme de clinicien-chercheur - Clinician Investigator Program certificate. Collège Royal des Médecins et Chirurgiens du Canada.

Expérience académique

(2019) Professeur titulaire - Full Professor. Université de Sherbrooke.

(2011-2016) Directeur de la recherche, programme de médecine interne générale - Director of Research, General internal medicine program. Université de Sherbrooke.

(2009-2014) Professeur adjoint - Assistant professor. Université de Sherbrooke.

Présentation

Sujets de recherche

Choc septique, Soins intensifs, Système cardiovasculaire.

Disciplines de recherche

Épidémiologie et biostatistique.

Mots-clés

Corticostéroïdes, Essais cliniques, Études observationnelles, Respiration artificielle, Revues systématiques, SDRA, Sepsis, Soins intensifs, Vasopresseurs, Vitamine C.

Recherche clinique

Oui

Centre de recherche

Centre de recherche du CHUS

Langues parlées et écrites

Anglais, Espagnol (castillan), Français

Prix et distinctions

  • Award of excellence. Université de Sherbrooke. (Distinction).
  • Best publication award. Health Research Methodology program (McMaster). (Distinction).
  • Chercheur du mois CRCHUS. Centre Hospitalier Univ. de Sherbrooke. (Distinction).
  • Foundation Resident Prize 2009. Ontario Physicians’ Services Incorporated (PSI). (Prix).
  • Jean de Margerie Award (In recognition of the publication of the year in the field of biomedical science). Faculty of medicine and health sciences, Université de Sherbrooke. (Prix).
  • Jeune Chercheur André Dupont 2019 Award (In recognition for the excellence of work in the field of biomedical research). Club de Recherches Cliniques du Québec (CRCQ). (Prix).
  • Merck Patients First Award. Merck Research Laboratories. (Prix).
  • New Investigator Award 2013. Canadian Society of Internal Medicine (CSIM). (Distinction).
  • Personality of the year recognized by the TIME Magazine as for implication in Ebola crisis management. TIME Magazine. (Honneur).
  • Post-doctoral Publication Award. Association Médicale du Québec. (Distinction).
  • Recognition from the Public Health Agency of Canada for leadership in elaboration of the Guide de pratique clinique pour la prise en charge de la maladie à virus Ébola: Guide à l’intention des cliniciens de Canada. Public Health Agency of Canada. (Honneur).
  • Recognition of outstanding achievement in the fight against Ebola. Université de Sherbrooke. (Distinction).
  • Team award - Integration of research in clinical critical care. Gala d'excellence du CIUSSS de l'Estrie - CHUS. (Prix).
  • Tremplin en recherche et en création Award (In recognition of the outstanding contribution to research and creation). Université de Sherbrooke. (Prix).
  • Université de Sherbrooke Department of Medicine Gérard Eugène Plante Award (in recognition for outstanding research productivity). Département de médecine, Université de Sherbrooke. (Honneur).

Financement

Subvention. (Obtenu). Candidat principal. Canadian Sepsis Research Network: Improving CareBefore, During and After Sepsis. Instituts de Recherche en Santé du Canada (IRSC). Team Grant : Sepsis Research Network - LOI. 24970 $ (2020-2025).

Bourse de recherche. (Obtenu). Chercheur principal. Recherches évaluatives visant à améliorer l’efficacité et la sécurité des interventions en médecine de réanimation – vasopresseurs, lignes directrices axées sur le patient, boucle fermée et intelligence artificielle, vitamine C et le réseau SEPSIS. Fonds de recherche du Québec - Santé (FRQS). FRQS Senior. 158502 $ (2020-2024).

Subvention. (Obtenu). Cochercheur. Fluids in septic shock (FISSH): a randomized controlled trial. Institut Canadien de recherche sur la sant. Volet Projet. 1147501 $ (2020-2023).

Subvention. (Obtenu). Cochercheur. The Canadian Severe Acute Respiratory Infection, Prospective, Perpetual Observational Study: Informing Clinical Care and the Public Health Response. Instituts de Recherche en Santé du Canada (IRSC). COVID-19 Research Gaps and Priorities. Circulatory and Respiratory Health. 455175 $ (2020-2023).

Subvention. (Obtenu). Cochercheur. Living network meta-analysis and rapid recommendations for the treatment of COVID-19. Santé Canada. Subv fonct: Rech. rapide contre COVID-19-Gestion clinique/Interv. système santé. 1365525 $ (2020-2023).

Subvention. (Obtenu). Cochercheur. Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delaYed graft function trial (CINERGY) – Vanguard. Instituts de Recherche en Santé du Canada (IRSC). Project Grant - Infection and Immunity / Maladies infectieuses et immunitaires. 447525 $ (2021-2023).

Subvention. (Obtenu). Cochercheur. Recover Program: A Care Continuum after Critical Illness. Instituts de Recherche en Santé du Canada (IRSC). Team grant: Transitions in Care. 932280 $ (2019-2023).

Subvention. (Obtenu). Cochercheur. The Frequency of Screening and SBT Technique Trial: The FAST Trial (North American Weaning Collaborative). Instituts de Recherche en Santé du Canada (IRSC). Project grant. 1315800 $ (2018-2023).

Subvention. (Obtenu). Chercheur principal. Lessening Organ Dysfunction/Injury with Vitamin C - LOVIT Trial. Lotte & John Hecht Memorial Foundation. Research Grant. 2878000 $ (2018-2022).

Subvention. (Obtenu). Cochercheur. The Frequency of Screening and SBT Technique Trial: The FAST Trial (North American Weaning Collaborative). Instituts de Recherche en Santé du Canada (IRSC). IRSC Project grant. 1315800 $ (2017-2022).

Subvention. (Obtenu). Chercheur principal. The Canadian Network of COVID-19 Clinical Trials Networks. Instituts de Recherche en Santé du Canada (IRSC). IRSC - Operating grant. 6000000 $ (2021-2022).

Subvention. (Obtenu). Cochercheur. Canadian Adaptive Platform Trial in Intensive Care (CAPTIC) Program. Instituts de Recherche en Santé du Canada (IRSC). Operating Grant: SPOR Innovative Clinical Trial Multi-Year Grant. 1497200 $ (2018-2022).

Subvention. (Obtenu). Chercheur principal. Réseau québécois COVID - pandémie (RQCP). Fonds de recherche du Québec - Santé (FRQS). Initiatives dans le cadre de la pandémie COVID-19. 300000 $ (2020-2022).

Subvention. (Obtenu). Cochercheur. STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre,Randomized, Controlled Trial. Instituts de Recherche en Santé du Canada (IRSC). Project Grant: Fall 2017 and Spring 2018. 2035000 $ (2018-2022).

Subvention. (Obtenu). Cochercheur. Transfusion in traumatic brain injury (TSiTBI Trial). Instituts de Recherche en Santé du Canada (IRSC). CIHR Project Scheme: 2016 1st Live Pilot. 1139105 $ (2017-2022).

Subvention. (Obtenu). Cochercheur. COVID-19: Improving the Evidence to Treat an Emerging Infection Through Observational Studies and a Randomized Trial. Instituts de Recherche en Santé du Canada (IRSC). Subvention de fonctionnement/Operating Grant. 477468 $ (2020-2022).

Subvention. (Obtenu). Cochercheur. Automated Oxygen Titration, Monitoring and Weaning in patients with infectious pneumonia requiring oxygen - impact on the number of interventions for healthcare workers. An innovative device to manage patients with COVID-19 pneumonia. COVID study (Cl. Instituts de Recherche en Santé du Canada (IRSC). IRSC Operating grant. 829476 $ (2020-2022).

Subvention. (Obtenu). Cochercheur. COVID-19 Evidence Network to support Decision-making (COVID-END). Instituts de Recherche en Santé du Canada (IRSC). IRSC Operating grant. 1000000 $ (2020-2021).

Subvention. (Obtenu). Cochercheur. Ultra-Low Tidal Volume Mechanical Ventilation in ARDS Through ECCO2R (ULTIMATE) Pilot Trial. Instituts de Recherche en Santé du Canada (IRSC). IRSC Project grant. 520200 $ (2019-2021).

Subvention. (Obtenu). Cochercheur. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial. Instituts de Recherche en Santé du Canada (IRSC). CIHR Project Scheme: 2016 1st Live Pilot. 2010635 $ (2016-2021).

Subvention. (Obtenu). Cochercheur. Anticoagulation and Convalescent Plasma ICU Trials in REMAP-CAP. Instituts de Recherche en Santé du Canada (IRSC). IRSC Operating grant. 2176566 $ (2020-2021).

Subvention. (Obtenu). Chercheur principal. COVID-LOVIT - High Dose Intravenous Vitamin C for COVID-19 (Hetch ID #4530). Lotte & John Hecht Memorial Foundation. Research Grant. 1870000 $ (2020-2021).

Subvention. (Obtenu). Chercheur principal. Canadian COVID-19 Prospective Cohort Study (CanCOV). Instituts de Recherche en Santé du Canada (IRSC). IRSC Operating grant. 2112500 $ (2020-2021).

Subvention. (Obtenu). Cochercheur. HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION - IS THERE A PROTECTIVE EFFECT OF ARBs ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBs CORONA II). Instituts de Recherche en Santé du Canada (IRSC). IRSC Operating grant. 3456541 $ (2020-2021).

Subvention. (Obtenu). Cochercheur. Living network meta-analysis and Rapid Recommendations for the treatment of COVID-19. Instituts de Recherche en Santé du Canada (IRSC). IRSC Operating grant. 276315 $ (2020-2021).

Subvention. (Obtenu). Cochercheur. Sedating With Volatile Anesthetic Agents in Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival (The SAVE-ICU trial). Instituts de Recherche en Santé du Canada (IRSC). IRSC Operating grant. 2020648 $ (2020-2021).

Subvention. (Terminé). Cochercheur. Développement d'une boucle fermée pour améliorer la sécurité des agents vasoactifs. Centre de recherche du CHUS. Programme d'aide de financement interne (PAFI). 25000 $ (2019-2021).

Subvention. (Terminé). Cochercheur. Fluids in septic shock (FISSH): a randomized controlled trial. PSI Foundation. Research grant. 249500 $ (2018-2021).

Subvention. (Terminé). Cochercheur. REVISE: Re-Evaluating the Inhibition of Stress Erosions in the ICU. Instituts de Recherche en Santé du Canada (IRSC). Project Grant: Fall 2016. 1935832 $ (2017-2021).

Subvention. (Terminé). Cochercheur. Measuring baseline ascorbic acid levels in the Optimal Vasopressor Titration Trial. Lotte & John Hecht Memorial Foundation. Research Grant. 206800 $ (2018-2020).

Subvention. (Terminé). Chercheur principal. The Canadian Critical Care Trials Group. Instituts de Recherche en Santé du Canada (IRSC). IRSC Operating grant. 150000 $ (2020).

Bourse de recherche. (Terminé). Chercheur principal. Optimisation des VAsopresseurs pour le Traitement de l'hypotensION (OVATION). Fonds de recherche du Québec - Santé (FRQS). Clinician-Investigator Junior 2 Salary Award. 148772 $ (2016-2020).

Subvention. (Terminé). Cochercheur. Impacts de l'état auto-immun des donneurs d'organes sur la fonctionnalité du greffon chez les receveurs: une étude translationnelle. Centre de recherche du CHUS. Projets structurants. 75000 $ (2018-2020).

Subvention. (Terminé). Chercheur principal. The Ovation-65 trial - Impact of permissive hypotension on end-organ damage in the elderly. Centre de recherche du CHUS. SPOP axis. Matching funds. 12500 $ (2017-2020).

Subvention. (Terminé). Chercheur principal. Evaluating the clinical and cost effectiveness of using a more conservative mean arterial pressure target range to guide careful titration of vasopressors to minimise dose and duration in older criticaly ill patients with vasodilatory hypotension. National Institute for Health Research (NIHR) (UK). NIH Health Technology Assessment (Pound sterling). 1413497 $ (2017-2019).

Subvention. (Terminé). Chercheur principal. Effects of catecholamine therapy on the immune system: unsuspected consequences of routine medical interventions and opportunities for individualized care. Merck Sharp & Dohme. Research Grant. 67000 $ (2018-2019).

Subvention. (Terminé). Cochercheur. PROSPECT: Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial. Instituts de Recherche en Santé du Canada (IRSC). CIHR Project Scheme: 2016 1st Live Pilot. 1272893 $ (2016-2019).

Subvention. (Terminé). Cochercheur. Facteurs de risque et impacts de la carence en vitamine D chez les victimes de traumatisme craniocérébral modéré et grave: une étude rétrospective multicentrique.. Fonds de recherche du Québec - Santé (FRQS). Consortium pour le développement de la recherche en traumatologie - Volet 2. 19996 $ (2018-2019).

Subvention. (Terminé). Chercheur principal. Permissive hypotension to reduce organ injury - The OVATION-65 trial (Top ranked in presented committee). Instituts de Recherche en Santé du Canada (IRSC). Planning and Dissemination Grant– Institute Community Support. 15000 $ (2017-2019).

Subvention. (Terminé). Cochercheur. Frequency of Screening and SBT Technique Trial (the FAST Trial): A Factorial Design RCT. Instituts de Recherche en Santé du Canada (IRSC). Project Grant: Fall 2016. 100000 $ (2017-2018).

Subvention. (Terminé). Chercheur principal. Informer davantage les proches des usagers de la recherche aux soins intensifs. Fondation du CHUS (Sherbrooke, QC). Fonds Brigitte Perreault. 8850 $ (2017-2018).

Subvention. (Terminé). Chercheur principal. The 65 trial: Linking bench to bedside. Centre de recherche du CHUS. Programme d’octroi de fonds de l’axe Santé des populations. 4500 $ (2016-2017).

Subvention. (Terminé). Chercheur principal. Optimal vasopressor titration (OVATION) Observational study. Fonds de recherche du Québec - Santé (FRQS). Research Grant. 270000 $ (2013-2016).

Subvention. (Terminé). Cochercheur. Establishing Feasibility & Safety of Providing Critical Care for Patients with Ebola through design of a simulated Ebola Treatment Centre. Instituts de Recherche en Santé du Canada (IRSC). IRSC Operating grant. 249973 $ (2015-2016).

Subvention. (Terminé). Cochercheur. Gone, but not forgotten: A prospective cohort study to characterize the health effects of post-Ebola syndrome on survivors of Ebola Virus Disease in West Africa. Instituts de Recherche en Santé du Canada (IRSC). IRSC Operating grant. 250000 $ (2015-2016).

Subvention. (Terminé). Cochercheur. A National Strategy on Quality of Care Research and Evaluation - With the Patient for the Patient. Instituts de Recherche en Santé du Canada (IRSC). Planification et dissémination - ISCR. 25000 $ (2015-2016).

Bourse de recherche. (Terminé). Chercheur principal. Fonds de démarrage. Université de Sherbrooke. Fond de démarrage. 45000 $ (2009).

Publications

Articles de revue

  • Lau VI , Xie F , Basmaji J , Cook DJ , Fowler R , Kiflen M , Sirotich E , Iansavichene A , Bagshaw SM , Wilcox ME , Lamontagne F , Ferguson N , Rochwerg B. (2021). Health-Related Quality-of-Life and Cost Utility Analyses in Critical Care: A Systematic Review. Critical care medicine, NA, NA. (Article publié).
  • Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AA, Arabi YM, Annane D, Beane A, van Bentum-Puijk W, Berry LR, Bhimani Z, Bonten M, Badbury CA, Brunkhorst FM, Buzgau A, Cheng AC, Detry MA, Duffy EJ, Estcourt LJ, Fitzgerald M, Goossens H, Haniffa R, Higgins AM, Hills TE, Horvat CM, Lamontagne F, Lawler PR, Leavis HL, Linstrum KM, Litton E, Lorenzi E, Marshall JC, Mayr FB, McAuley D, McGlothlin A, McGuinness SP, McVerry BJ, Montgomery SK, Morphet SC, Murthy S, Orr K, Parke RL, Parker JC, Patanwala AE, Rademaker E, Santos MS, Saunders CT, Seymour CW, Shankar-Hari M, Sligl WI, Turgeon AF, Turner AM, van de Veerdonk FL, Zarychanski R, Green C, Lewis R, Angus DC, McArthur CJ, Berry S, Webb SA, Derde LPG. (2021). Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 –Preliminary report. MedRxiv, NA, NA. DOI. (Article accepté).
  • Bartoszko JJ, Siemieniuk R AC, Kum E, Qasim A, Zeraatkar D,Ge L,Han M A, Sadeghirad B, Agarwal A, Agoritsas T, Chu DK, Couban R, Darzi AJ, Devji T, Ghadimi M, Honarmand K, Izcovich A, Khamis A, Lamontagne F, Loeb M, Marcucci M, McLeod SL, Motaghi S, Murthy S, Mustafa RA, Neary JD, Pardo-Hernandez H, Rada G, Rochwerg B, Switzer C, Tendal B, Thabane L, Vandvik PO, Vernooij R WM, Viteri-Garcia A, Wang Y, Yao L, Ye Z, Guyatt GH, Brignardello-Petersen R. (2021). Prophylaxis for covid-19: living systematic review and network meta-analysis. medRxiv, NA, NA. DOI. (Article accepté).
  • Mouncey P R, Richards-Belle A, Thomas K, Harrison D A, Sadique M Z, Grieve R D, Camsooksai J, Darnell R, Gordon A C, Henry D, Hudson N, Mason A J, Saull M, Whitman C, Young J D, Lamontagne F, Rowan K M. (2021). Reduced exposure to vasopressorsthrough permissive hypotension to reduce mortality in critically ill peopleaged 65 and over: the 65 RCT. Health Technology Assessment., 25(14), NA. DOI. (Article publié).
  • Agarwal A, Fernando SM, Honarmand K, Bakaa L, Brar S, Granton D, Chaudhuri D, Chetan D, Hu M, Basmaji J, Muttalib F, Rochwerg B, Adhikari NKJ, Lamontagne F, Murthy S, Hui DS, Gomersall CD, Mubareka S, Diaz J, Burns KEA, Couban R, Vandvik PO. (2021). Risk of dispersion or aerosol generation and infection transmission with nasopharyngeal and oropharyngeal swabs for detection of COVID-19: a systematic review. BMJ Open, 11(03), e040616. DOI. (Article publié).
  • Burns K, Cheng M, Lee T, McGeer A, Sweet D, Tran K, Lee T, Murthy S, Boyd J, Singer J, Walley K, Patrick D, Lamontagne F, Marshall JC, Haljan G, Fowler R, Winston B, Russell J. January 13th, 2021. (2021). Sustained Dysregulation of the Plasma Renin-angiotensin System in Acute COVID-19. Research Square, NA, NA. DOI. (Article soumis).
  • Sauro KM , Soo A , de Grood C , Yang MMH , Wierstra B , Benoit L , Couillard P , Lamontagne F , Turgeon AF , Forster AJ , Fowler RA , Dodek PM , Bagshaw SM , Stelfox HT. (2020). Adverse Events After Transition From ICU to Hospital Ward: A Multicenter Cohort Study. Critical care medicine, 48(7), 946-953. (Article publié).
  • WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group , Sterne JAC , Murthy S , Diaz JV , Slutsky AS , Villar J , Angus DC , Annane D , Azevedo LCP , Berwanger O , Cavalcanti AB , Dequin PF , Du B , Emberson J , Fisher D , Giraudeau B , Gordon AC , Granholm A , Green C , Haynes R , Heming N , Higgins JPT , Horby P , Jüni P , Landray MJ , Le Gouge A , Leclerc M , Lim WS , Machado FR , McArthur C , Meziani F , Møller MH , Perner A , Petersen MW , Savovic J , Tomazini B , Veiga VC , Webb S , Marshall JC. (2020). Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA, 324(13), 1330-1341. DOI. (Article publié).
  • Honarmand K, Penn J, Agarwal A, Siemieniuk R, Brignardello-Petersen R, Bartoszko JJ, Zeraatkar D, Agoritsas T, Burns K, Fernando S M, Foroutan F, Ge L, Lamontagne F, Jimenez-Mora MA, MurthyS, Yepes Nuñez J J, Vandvik P O, Ye Z, Rochwerg B. (2020). Clinical Trials in COVID-19 Management & Prevention: A Meta-epidemiological Study examining methodological quality. medRxiv, NA, NA. DOI. (Article soumis).
  • Siemieniuk RA, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Pardo-Hernandez H, Rochwerg B, Lamontagne F, Han MA, Kum E, Liu Q, Agarwal A, Agoritsas T, Alexander P, Chu DK, Couban R, Darzi A, Devji T, Fang B, Fang C, Flottorp SA, Foroutan F, Heels-Ansdell D, Honarmand K, Hou L, Hou X, Ibrahim Q, Loeb M, Marcucci M, McLeod SL, Motaghi S, Murthy S, Mustafa RA, Neary JD, Qasim A, Rada G, Riaz IB, Sadeghirad B, Sekercioglu N, Sheng L, Switzer C, Tendal B, Thabane L, Tomlinson G, Turner T, Vandvik PO, Vernooij RW, Viteri-García A, Wang Y, Yao L, Ye Z, Guyatt GH, Brignardello-Petersen R. (2020). Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ., 370, m2980. DOI. (Article publié).
  • Lau VI , Cook DJ , Fowler R , Rochwerg B , Johnstone J , Lauzier F , Marshall JC , Basmaji J , Heels-Ansdell D , Thabane L , Xie F , PROSPECT Collaborators. (2020). Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol. BMJ open, 10(6), e036047. (Article publié).
  • Writing Committee for the REMAP-CAP Investigators , Angus DC , Derde L , Al-Beidh F , Annane D , Arabi Y , Beane A , van Bentum-Puijk W , Berry L , Bhimani Z , Bonten M , Bradbury C , Brunkhorst F , Buxton M , Buzgau A , Cheng AC , de Jong M , Detry M , Estcourt L , Fitzgerald M , Goossens H , Green C , Haniffa R , Higgins AM , Horvat C , Hullegie SJ , Kruger P , Lamontagne F , Lawler PR , Linstrum K , Litton E , Lorenzi E , Marshall J , McAuley D , McGlothin A , McGuinness S , McVerry B , Montgomery S , Mouncey P , Murthy S , Nichol A , Parke R , Parker J , Rowan K , Sanil A , Santos M , Saunders C , Seymour C , Turner A , van de Veerdonk F , Venkatesh B , Zarychanski R , Berry S , Lewis RJ , McArthur C , Webb SA , Gordon AC. (2020). Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA, 324(10), 1317-1329. (Article publié).
  • Lamontagne F , Richards-Belle A , Thomas K , Harrison DA , Sadique MZ , Grieve RD , Camsooksai J , Darnell R , Gordon AC , Henry D , Hudson N , Mason AJ , Saull M , Whitman C , Young JD , Rowan KM , Mouncey PR , 65 trial investigators. (2020). Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial. JAMA, 323(10), 938-949. (Article publié).
  • Thomas K, Patel A, Sadique MZ, Grieve RD, Mason AJ, Moler S, Gordon AC, Rowan KM, Mouncey PR, Lamontagne F, Harrison DA. (2020). Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Statistical and health economic analysis plan for the 65 trial in article. J Intensive Care Soc., 21(3), 230-231. DOI. (Article publié).
  • Agarwal A, Basmaji J, Muttalib F, Granton D, Chaudhuri D, Chetan D, Hu M, Fernando SM, Honarmand K, Bakaa L, Brar S, Rochwerg B, Adhikari NK, Lamontagne F, Murthy S, Hui DSC, Gomersall C, Mubareka S, Diaz JV, Burns KEA, Couban R, Ibrahim Q, Guyatt GH, Vandvik PO. (2020). High-flow Nasal Cannula for Acute Hypoxemic Respiratory Failure in Patients With COVID-19: Systematic Reviews of Effectiveness and Its Risks of Aerosolization, Dispersion, and Infection Transmission. Can J Anaesth., ND(ND), 1-32. DOI. (Article publié).
  • François Lamontagne, Kathryn M Rowan, Gordon Guyatt. (2020). Integrating research into clinical practice: challenges and solutions for Canada. CMAJ, NA, NA. DOI. (Article publié).
  • Moore L, Tardif PA, Lauzier F, Bérubé M, Archambault P, Lamontagne F, Chassé M, Stelfox HT, Gabbe B, Lecky F, Kortbeek J, Lessard-Bonaventure P, Truchon C, Turgeon AF. (2020). LOW-VALUE CLINICAL PRACTICES IN ADULT TRAUMATIC BRAIN INJURY: AN UMBRELLA REVIEW. J Neurotrauma., ahead of print, ahead of print. DOI. (Article sous presse).
  • Rochwerg, B., Parke, R., Murthy, S., Fernando, S., Leigh, J., Marshall, J., Adhikari, N., Fiest, K., Fowler, R., Lamontagne, F., Sevransky, J. (2020). Misinformation During the Coronavirus Disease 2019 Outbreak: How Knowledge Emerges From Noise. Critical Care Explorations, 2(4), p.e0098. (Article publié).
  • Masse MH, Battista MC, Wilcox EM, Pinto R, Marinoff N, D’Aragon F, St-Arnaud C, Mayette M, Leclair MA, Quirox Martinez H, Grondin-Beaudoin B, Poulin Y, Carbonneau É, Seely A JE, Watpool I, Porteous R, Chassé M, Lebrasseur M, Lauzier F, Turgeaon AF, Bellemare D, Mehta S, Charbonney E, Belley-Côté É, Botton É, Cohen D, Lamontagne F, Adhikari N. (2020). Optimal VAsopressorTitraTION in patients 65 years and older (OVATION-65) : protocal andstatistical analysis plan for a randomised clinical trial. 10, 037947. DOI. (Article publié).
  • Kasenda B, Liu J, Jiang Y, Gajewski B, Wu C, von Elm E, Schandelmaier S, Moffa G, Trelle S, Schmitt AM, Herbrand AK, Gloy V, Speich B, Hopewell S, Hemkens LG, Sluka C, McGill K, Meade M, Cook D, Lamontagne F, Tréluyer JM, Haidich AB, Ioannidis JPA, Treweek S, Briel M. (2020). Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)-rationale and design for an international collaborative study. Trials, 21(1), 731. DOI. (Article publié).
  • Heyland DK , Marquis F , Lamontagne F , Albert M , Turgeon AF , Khwaja KA , Garland A , Hall R , Chapman MG , Kutsiogannis DJ , Martin C , Sessler DI , Day AG. (2020). Promotion of Regular Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in Long-Stay ICU Patients. A Multicenter, Phase II, Sham-Controlled, Randomized Trial: The PROPEL Study. Critical care medicine, 48(3), e219-e226. (Article publié).
  • Lamontagne F , Mouncey PR. (2020). Reducing Vasopressor Exposure in Patients With Vasodilatory Hypotension-Reply. JAMA, 324(9), 898-899. (Article publié).
  • Das SK , Choupoo NS , Ray S. (2020). Reducing Vasopressor Exposure in Patients With Vasodilatory Hypotension. JAMA, 324(9), 897-898. (Article publié).
  • WHO Solidarity Trial Consortium , Pan H , Peto R , Henao-Restrepo AM , Preziosi MP , Sathiyamoorthy V , Abdool Karim Q , Alejandria MM , Hernández García C , Kieny MP , Malekzadeh R , Murthy S , Reddy KS , Roses Periago M , Abi Hanna P , Ader F , Al-Bader AM , Alhasawi A , Allum E , Alotaibi A , Alvarez-Moreno CA , Appadoo S , Asiri A , Aukrust P , Barratt-Due A , Bellani S , Branca M , Cappel-Porter HBC , Cerrato N , Chow TS , Como N , Eustace J , García PJ , Godbole S , Gotuzzo E , Griskevicius L , Hamra R , Hassan M , Hassany M , Hutton D , Irmansyah I , Jancoriene L , Kirwan J , Kumar S , Lennon P , Lopardo G , Lydon P , Magrini N , Maguire T , Manevska S , Manuel O , McGinty S , Medina MT , Mesa Rubio ML , Miranda-Montoya MC , Nel J , Nunes EP , Perola M , Portolés A , Rasmin MR , Raza A , Rees H , Reges PPS , Rogers CA , Salami K , Salvadori MI , Sinani N , Sterne JAC , Stevanovikj M , Tacconelli E , Tikkinen KAO , Trelle S , Zaid H , Røttingen JA , Swaminathan S. (2020). Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. The New England journal of medicine, ahead of print, ahead of print. DOI. (Article publié).
  • D'Aragon F, Burns KEA, Yaworski A, Lucas A, Arseneau E, Belley-Cote E, Dhanani S, Frenette AJ, Lamontagne F, Lauzier F, Akhtar A, Oczkowski S, Rochwerg B, Meade MO. (2020). Research Consent Models Used in Prospective Studies of Neurologically Deceased Organ Donors: A Systematic Review. Journal of Empirical Research on Human Research Ethics, NA(NA), NA. (Article publié).
  • ISARIC Clinical Characterisation Group , Pritchard MG , Olliaro PL. (2020). Symptoms at presentation for patients admitted to hospital with Covid-19: results from the ISARIC prospective multinational observational study. medRxiv : the preprint server for health sciences, NA, NA. (Article publié).
  • Angus DC, Berry S, Lewis RJ, Al-Beidh F, Arabi Y, van Bentum-Puijk W, Bhimani Z, Bonten M, Broglio K, Brunkhorst F, Cheng AC, Chiche JD, De Jong M, Detry M, Goossens H, Gordon A, Green C, Higgins AM, Hullegie SJ, Kruger P, Lamontagne F, Litton E, Marshall J, McGlothlin A, McGuinness S, Mouncey P, Murthy S, Nichol A, O'Neill GK, Parke R, Parker J, Rohde G, Rowan K, Turner A, Young P, Derde L, McArthur C, Webb SA. (2020). The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Ann Am Thorac Soc, 17(7), 879-891. DOI. (Article publié).
  • Angus DC , Berry S , Lewis RJ , Al-Beidh F , Arabi Y , van Bentum-Puijk W , Bhimani Z , Bonten M , Broglio K , Brunkhorst F , Cheng AC , Chiche JD , De Jong M , Detry M , Goossens H , Gordon A , Green C , Higgins AM , Hullegie SJ , Kruger P , Lamontagne F , Litton E , Marshall J , McGlothlin A , McGuinness S , Mouncey P , Murthy S , Nichol A , O'Neill GK , Parke R , Parker J , Rohde G , Rowan K , Turner A , Young P , Derde L , McArthur C , Webb SA. (2020). The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and Design. Annals of the American Thoracic Society, 17(7), 879-891. (Article publié).
  • STARRT-AKI Investigators; Canadian Critical Care Trials Group, the Australian and New Zealand Intensive Care Society Clinical Trials Group, the United Kingdom Critical Care Research Group, the Canadian Nephrology Trials Network, and the Irish Critical Care Trials Group, Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, Du B, Gallagher MP, Gaudry S, Hoste EA, Lamontagne F, Joannidis M, Landoni G, Liu KD, McAuley DF, McGuinness SP, Neyra JA, Nichol AD, Ostermann M, Palevsky PM, Pettilä V, Quenot JP, Qiu H, Rochwerg B, Schneider AG, Smith OM, Thomé F, Thorpe KE, Vaara S, Weir M, Wang AY, Young P, Zarbock A. (2020). Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med., 383(3), 240-251. DOI. (Article publié).
  • Lamontagne F, Angus DC. (2020). Toward Universal Deployable Guidelines for the Care of Patients With COVID-19. JAMA, 323(18), 1786-1787. DOI. (Article publié).
  • D'Aragon F, Lamontagne F, Cook D, Dhanani S, Keenan S, Chassé M, English S, Burns KEA, Frenette AJ, Ball I, Boyd JG, Masse MH, Breau R, Akhtar A, Kramer A, Rochwerg B, Lauzier F, Kutsogiannis DJ, Ibrahim Q, Hand L, Zhou Q, Meade MO; Canadian Critical Care Trials Group and the Canadian Donation and Transplant Research Program. (2020). Variability in Deceased Donor Care in Canada: A Report of the Canada-DONATE Cohort Study. Can J Anaesth, NA(NA), NA. DOI. (Article publié).
  • Walker SE , Iazzetta J , Law S , Kanji S , Bolduc B , Lamontagne F , Adhikari NKJ. (2019). Administration of Intravenous Ascorbic Acid-Practical Considerations for Clinicians. Nutrients, 11(9), 1994. (Article publié).
  • Lee JS, Adhikari NKJ, Kwon HY, Teo K, Siemieniuk R, Lamontagne F, Chan A, Mishra S, Murthy S, Kiiza P, Hajek J, Bah EI, Lamah MC, Kao R, Fowler RA. (2019). Anti-Ebola therapy for patients with Ebola virus disease: a systematic review. BMC Infect Dis. (Impact factor: 2.951), 19(1), 376. (Article publié).
  • Tlayjeh H, Arabi YM, Ferguson ND, Zhou Q, Lamontagne F, Arroliga A, Danesh V, Dominguez-Cherit G, Jimenez E, Mullaly A, Staub B, Meade MO; Canadian Critical Care Trials Group. (2019). Body Mass Index and Mortality in Subjects With ARDS: Post-hoc Analysis of the OSCILLATE Trial. Respir Care. (Impact factor: 1.736), NA, NA. (Article publié).
  • Belley-Cote EP, Lamy A, Devereaux PJ, Kavsak P, Lamontagne F, Cook DJ, Kennedy K, Vincent J, Ou Y, Tagarakis G, Whitlock RP. (2019). Definitions of post-coronary artery bypass grafting myocardial infarction: variations in incidence and prognostic significance. Eur J Cardiothorac Surg (Impact factor: 3.847), NA, NA. (Article publié).
  • Hamilton M, Tomlinson G, Chu L, Robles P, Matte A, Burns S, Thomas C, Lamontagne F, Adhikari NKJ, Ferguson N, Friedrich JO, Rudkowski JC, Skrobik Y, Meggison H, Cameron J, Herridge M; RECOVER Program Investigators and the Canadian Critical Care Trials Group. (2019). Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of ? 7 Days of Mechanical Ventilation: Results From the RECOVER Program, a Secondary Analysis of a Prospective Multicenter Cohort Study. Chest (Impact factor: 9.657), pii: S0012-3692(19), 31046-31043. (Article publié).
  • Kearon C, de Wit K, Parpia S, Schulman S, Afilalo M, Hirsch A, Spencer FA, Sharma S, D'Aragon F, Deshaies JF, Le Gal G, Lazo-Langner A, Wu C, Rudd-Scott L, Bates SM, Julian JA; PEGeD Study Investigators [Lamontagne F = collaborator]. (2019). Diagnosis ofPulmonary Embolism with d-Dimer Adjusted to Clinical Probability. N Engl J Med (Impact factor: 70.670), 381(22), 2125-2134. (Article publié).
  • Prévost AS, Hylands M, Gervais M, Praud JP, Battista MC, Déziel-Malouin S, Lachance M6, Lamontagne F. (2019). Drug- induced sleep endoscopy compared with systematic adenotonsillectomy in the management of obstructive sleep apnoea in children: a systematic review and meta-analysis protocol. BMJ Open (Impact factor: 2.376), 9(9), e028242. (Article publié).
  • Garg AX, Chan MTV, Cuerden MS, Devereaux PJ, Abbasi SH, Hildebrand A, Lamontagne F, Lamy A, Noiseux N, Parikh CR, Perkovic V, Quantz M, Rochon A, Royse A, Sessler DI, Shah PJ, Sontrop JM, Tagarakis GI, Teoh KH, Vincent J, Walsh M, Yared JP, Yusuf S, Whitlock RP; SIRS Investigators. (2019). Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial. CMAJ (Impact factor: 6.8), 191(9), E247-E256. (Article publié).
  • Clément C, Adhikari NKJ, Lamontagne F. (2019). Evidence-Based Clinical Management of Ebola Virus Disease and Epidemic Viral Hemorrhagic Fevers. Infectious Disease Clinics of North America (Impact factor: 5.449), 33(1), 247-264. (Article publié).
  • Turgeon AF, Dorrance K, Archambault P, Lauzier F, Lamontagne F, Zarychanski R, Fowler R, Moore L, Lacroix J, English S, Boutin A, Muscedere J, Burns KEA, Griesdale D, McIntyre LA, Scales D, Bernard F, Yamada J, Squires JE; Canadian Traumatic Brain Injury Research Consortium and the Canadian Critical Care Trials Group. (2019). Factors influencing decisions by critical care physicians to withdraw life-sustaining treatments in critically ill adult patients with severe traumatic brain injury. CMAJ (Impact factor: 6.9), 191(24), E652-E663. (Article publié).
  • Burns KEA, Rizvi L, Cook DJ, Seely AJE, Rochwerg B, Lamontagne F, Devlin JW, Dodek P, Mayette M, Tanios M, Gouskos A, Kay P, Mitchell S, Kiedrowski KC, Hill NS; Canadian Critical Care Trials Group. (2019). Frequency of Screening and SBT Technique Trial - North American Weaning Collaboration (FAST-NAWC): a protocol for a multicenter, factorial randomized trial. Trials (Impact factor: 2.258), 20(1), 587. (Article publié).
  • Burns KEA, Wong JTY, Dodek P, Cook DJ, Lamontagne F, Cohen A, Mehta S, Kho ME, Hebert PC, Aslanian P, Friedrich JO, Brochard L, Rizvi L, Hand L, Meade MO, Amaral AC, Seely AJ; Canadian Critical Care Trials Group. (2019). Frequency of Screening for Weaning From Mechanical Ventilation: Two Contemporaneous Proof-of-Principle Randomized Controlled Trials. Crit Care Med.(Impact factor: 7.442), 47(6), 817-825. (Article publié).
  • Masse MH, Ménard J, Sprague S, Battista MC, Cook DJ, Guyatt GH, Heyland DK, Kanji S, Pinto R, Day AG, Cohen D, Annane D, McGuinness S, Parke R, Carr A, Arabi Y, Kumar B, Vijayaraghavan T, D'Aragon F, Carbonneau E, Maslove D, Hunt M, Rochwerg B, Millen T, Chassé M, Lebrasseur M, Archambault P, Deblois E, Drouin C, Lellouche F, Lizotte P, Watpool I, Porteous R, Clarke F, Marinoff N, Belley-Côté E, Bolduc B, Walker S, Iazetta J, Adhikari N, Lamontagne F. (2019). Lessening Organ dysfunction with VITaminC (LOVIT): protocol for a randomized controlled trial. Trials (Impact factor: 1.975), 21(1), 42. (Article publié).
  • Tardif PA, Moore L, Lauzier F, Farhat I, Archambault P, Lamontagne F, Chassé M, Stelfox HT, Gabbe BJ, Lecky F, Kortbeek J, Lessard-Bonaventure P, Truchon C, Turgeon AF. (2019). Low-value clinical practices in adult traumatic brain injury: an umbrella review protocol. BMJ Open (Impact Factor: 2.376), 9(10), e031747.
  • Moore L, Lauzier F, Tardif PA, Boukar KM, Farhat I, Archambault P, Mercier É, Lamontagne F, Chassé M, Stelfox HT, Berthelot S, Gabbe B, Lecky F, Yanchar N, Champion H, Kortbeek J, Cameron P, Bonaventure PL, Paquet J, Truchon C, Turgeon AF; Canadian Traumatic brain injury Research Consortium. (2019). Low-value clinical practices in injury care: A scoping review and expert consultation survey. J Trauma Acute Care Surg. (Impact factor: 3.403), 86(6), 983-993. (Article publié).
  • Kuhn JH, Adachi T, Adhikari NKJ, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH, Chertow DS, Chute CG, Cieslak TJ, Colebunders R, Crozier I, Davey RT, de Clerck H, Delgado R, Evans L, Fallah M, Fischer WA 2nd, Fletcher TE, Fowler RA, Grünewald T, Hall A, Hewlett A, Hoepelman AIM, Houlihan CF, Ippolito G, Jacob ST, Jacobs M, Jakob R, Jacquerioz FA, Kaiser L, Kalil AC, Kamara RF, Kapetshi J, Klenk HD, Kobinger G, Kortepeter MG, Kraft CS, Kratz T, Bosa HSK, Lado M, Lamontagne F, Lane HC, Lobel L, Lutwama J, Lyon GM 3rd, Massaquoi MBF, Massaquoi TA, Mehta AK, Makuma VM, Murthy S, Musoke TS, Muyembe-Tamfum JJ, Nakyeyune P, Nanclares C, Nanyunja M, Nsio-Mbeta J, O'Dempsey T, Paw?ska JT, Peters CJ, Piot P, Rapp C, Renaud B, Ribner B, Sabeti PC, Schieffelin JS, Slenczka W, Soka MJ, Sprecher A, Strong J, Swanepoel R, Uyeki TM, van Herp M, Vetter P, Wohl DA, Wolf T, Wolz A, Wurie AH, Yoti Z. (2019). New filovirus disease classification and nomenclature. Nat Rev Microbiol. (Impact factor: 31.851), 17(5), 261-263. (Article publié).
  • Mampuya WM, Dumont J, Lamontagne F. (2019). Norepinephrine-associated left ventricular outflow tract obstruction and systolic anterior movement. BMJ Case Reports, 12, e225879.
  • Williamson D, Frenette AJ, Burry LD, Perreault M, Charbonney E, Lamontagne F, Potvin MJ, Giguère JF, Mehta S, Bernard F. (2019). Pharmacological interventions for agitated behaviours in patients with traumatic brain injury: a systematic review. BMJ Open (Impact factor: 2.376), 9(7), e029604. (Article publié).
  • Battista MC, Loignon C, Benhadj L, Nouvet E, Murthy S, Fowler R, Adhikari NKJ, Haj-Moustafa A, Salam AP, Chan AK, Mishra S, Couturier F, Hudon C, Horby P, Bedell R, Rekart M, Hajek J, Lamontagne F. (2019). Priorities, Barriers, and Facilitators towards International Guidelines for the Delivery of Supportive Clinical Care during an Ebola Outbreak: A Cross-Sectional Survey. Viruses (Impact factor: 3.761), 11(2), E194. (Article publié).
  • Shemilt M, Boutin A, Lauzier F, Zarychanski R, Moore L, McIntyre LA, Nadeau L, Fergusson DA, Mercier E, Archambault P, Lamontagne F, Perron C, Léger C, Turgeon AF. (2019). Prognostic Value of Glial Fibrillary Acidic Protein in Patients With Moderate and Severe Traumatic Brain Injury: A Systematic Review and Meta-Analysis. Crit Care Med (Impact factor: 7.442), 47(6), e522-e529. (Article publié).
  • Bagshaw SM, Adhikari NKJ, Burns KEA, Friedrich JO, Bouchard J, Lamontagne F, McIntrye LA, Cailhier JF, Dodek P, Stelfox HT, Herridge M, Lapinsky S, Muscedere J, Barton J, Griesdale D, Soth M, Ambosta A, Lebovic G, Wald R; Canadian Critical Care Trials Group. (2019). Selection and Receipt of Kidney Replacement in Critically Ill Older Patients with AKI. Clin J Am Soc Nephrol. (Impact factor 6.243), 14(4), 496-505. (Article publié).
  • Belley-Cote EP , Whitlock RP , Ulic DV , Honarmand K , Khalifa A , McClure GR , Gibson A , Alshamsi F , D'Aragon F , Rochwerg B , Duan E , Savija N , Karachi T , Lamontagne F , Kavsak P , Cook DJ. (2019). The PROTROPIC feasibility study: prognostic value of elevated troponins in critical illness. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 66(6), 648-657. (Article publié).
  • Lamontagne F, Clément C, Kojan R, Godin M, Kabuni P, Fowler RA. (2019). The evolution of supportive care for Ebola virus disease. Lancet (Impact factor: 53.254), 393(10172), 620-621. (Article publié).
  • Angriman F, Ferreyro BL, Donaldson L, Cuthbertson BH, Ferguson ND, Bollen CW, Bachman TE, Lamontagne F, Adhikari NKJ. (2019). The harm of high-frequency oscillatory ventilation (HFOV) in ARDS is not related to a high baseline risk of acute cor pulmonale or short-term changes in hemodynamics. Intensive Care Med., 46(1), 132-134. (Article publié).
  • Daneman N, Rishu AH, Pinto R, Aslanian P, Bagshaw SM, Carignan A, Charbonney E, Coburn B, Cook DJ, Detsky ME, Dodek P, Hall R, Kumar A, Lamontagne F, Lauzier F, Marshall JC, Martin CM, McIntyre L, Muscedere J, Reynolds S, Sligl W, Stelfox HT, Wilcox ME, Fowler RA; Canadian Critical Care Trials Group. (2018). 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial. Trials (Impact factor: 2.067), 19(1), 111. (Article publié).
  • McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, Lamontagne F, Healey JS, Whitlock RP, Belley-Côté EP. (2018). Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis. JAMA (Impact factor: 47.661), 319(18), 1889-1900. (Article publié).
  • Loignon C, Nouvet E, Couturier F, Benhadj L, Adhikari NKJ, Murthy S, Fowler RA, Lamontagne F. (2018). Barriers to supportive care during the Ebola virus disease outbreak in West Africa: Results of a qualitative study. PLoS One (Impact factor: 2.766), 13(9), e0201091. (Article publié).
  • Lamontagne F, D'Aragon F, Burns K, Belley-Cote EP, Kho M, Menon K, Duan E, Masse MH, Archambault PM, Hrymak C, Rochwerg B. (2018). Canadian Critical Care Society - Revised process for guidelines development and endorsement. Canadian Journal of Anesthesia (Impact factor: 3.377), 65(10), 1163-1164. (Article publié).
  • Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B; Canadian Critical Care Trials Group. (2018). Chloride and Other Electrolyte Concentrations in Commonly Available 5% Albumin Products. Crit Care Med. (Impact factor: 7.050), 46(4), e326-e329. (Article publié).
  • Masse MH*, Richard MA, D'Aragon F, St-Arnaud C, Mayette M, Adhikari NKJ, Fraser W, Carpentier A, Palanchuck S, Gauthier D, Lanthier L, Touchette M, Lamontagne A, Chénard J, Mehta S, Sansoucy Y, Croteau E, Lepage M, Lamontagne F. (2018). Early Evidence of Sepsis-Associated Hyperperfusion-A Study of Cerebral Blood Flow Measured With MRI Arterial Spin Labeling in Critically Ill Septic Patients and Control Subjects. Crit Care Med. (Impact factor: 7.442), 46(7), e663-e669. (Article publié).
  • Lamontagne F, Fowler RA, Adhikari NK, Murthy S, Brett-Major DM, Jacobs M, Uyeki TM, Vallenas C, Norris SL, Fischer WA Nd, Fletcher TE, Levine AC, Reed P, Bausch DG, Gove S, Hall A, Shepherd S, Siemieniuk RA, Lamah MC, Kamara R, Nakyeyune P, Soka MJ, Edwin A, Hazzan AA, Jacob ST, Elkarsany MM, Adachi T, Benhadj L, Clément C, Crozier I, Garcia A, Hoffman SJ, Guyatt GH. (2018). Evidence-based guidelines for supportive care of patients with Ebola virus disease. The Lancet (Impact factor: 47·831), 391(10121), 700-708. (Article publié).
  • Dunberry-Poissant S, Gilbert K, Bouchard C, Baril F, Cardinal AM, L'Ecuyer S, Hylands M4, Lamontagne F, Rousseau G, Charbonney E. (2018). Fluid sparing and norepinephrine use in a rat model of resuscitated haemorrhagic shock: end-organ impact. Intensive Care Med Exp., 6(1), 47. (Article publié).
  • Leblanc G, Boutin A, Shemilt M, Lauzier F, Moore L, Potvin V, Zarychanski R, Archambault P, Lamontagne F, Léger C, Turgeon AF. (2018). Incidence and impact of withdrawal of life-sustaining therapies in clinical trials of severe traumatic brain injury: A systematic review. Clin Trials. (Impact factor: 2.715), 15(4), 398-412. (Article publié).
  • Walkey A, Adhikari NK, Day AG, Radermacher P, Asfar P, Lamontagne F. (2018). Mediation Analysis of High Blood Pressure Targets, Arrhythmias, and Shock Mortality. Am J Respir Crit Care Med. (Impact factor: 15.24), NA, NA. (Article publié).
  • Deane AM , Lamontagne F , Dukes GE , Neil D , Vasist L , Barton ME , Hacquoil K , Ou X , Richards D , Stelfox HT , Mehta S , Day AG , Chapman MJ , Heyland DK. (2018). Nutrition Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double-Blind, Placebo-Controlled Trial of the Motilin Receptor Agonist Camicinal (GSK962040): The NUTRIATE Study. JPEN. Journal of parenteral and enteral nutrition, 42(5), 949-959. (Article publié).
  • Lamontagne F, Day AG, Meade MO, Cook DJ, Guyatt GH, Hylands M*, Radermacher P, Chrétien JM, Beaudoin N, Hébert P, D'Aragon F, Meziani F, Asfar P. (2018). Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med. (Impact factor: 12.015), 44(1), 12-21. (Article publié).
  • Ishii J, Ohshimo S, Shime N, Lamontagne F, Guyatt G, Asfar P. (2018). Target blood pressure for septic and vasodilatory shock: what is optimal?. Intensive Care Med.(Impact factor: 10.125), 44(4), 548-549. (Article publié).
  • Brown KN, Leigh JP, Kamran H, Bagshaw SM, Fowler RA, Dodek PM, Turgeon AF, Forster AJ, Lamontagne F, Soo A, Stelfox HT. (2018). Transfers from intensive care unit to hospital ward: a multicentre textual analysis of physician progress notes. Crit Care (Impact factor: 5.358), 22(1), 19. (Article publié).
  • Langlois PL, Manzanares W, Adhikari NKJ, Lamontagne F, Stoppe C, Hill A, Heyland DK. (2018). Vitamin C Supplementation in the Critically Ill: A Systematic Review and Meta-Analysis. JPEN J Parenter Enteral Nutr. (Impact factor: 4.249), NA, NA. (Article publié).
  • L Langlois P, Lamontagne F. (2018). Vitamin C for the critically ill: Is the evidence strong enough?. Nutrition (Impact factor: 3.734), 60, 185-190. (Article publié).
  • Hylands M*, Hylander M, Asfar P, Toma A, Frenette AJ, Beaudoin N*, Belley-Côté EP*, D'Aragon F, Siemieniuk R, Charbonney E, Laake J, Lauzier F, Kwong J, Rochwerg B, Vandvik P, Guyatt G, Lamontagne F. (2017). A Systematic review of vasopressor blood pressure targets in critically ill adults with hypotension. Canadian Journal of Anesthesia (Impact factor: 3.377), 64(7), 703-715. (Article publié).
  • Stelfox HT, Leigh JP, Dodek PM, Turgeon AF, Forster AJ, Lamontagne F, Fowler RA, Soo A, Bagshaw SM. (2017). A multi-center prospective cohort study of patient transfers from the intensive care unit to the hospital ward. Intensive Care Med. (Impact factor: 12.015), 43(10), 1485-1494. (Article publié).
  • Rigal R, Valiani S, Stelfox T, Muscedere J, Martin C, Dodek P, Lamontagne F, Fowler R, Geshmy A, Cook D, Forster A, Hebert P, Milot D. (2017). An environmental scan of quality indicators in critical care. CMAJ Open (Impact factor: 6.243), 5(2), E488-E4995. (Article publié).
  • Maslove DM, Lamontagne F, Marshall JC, Heyland DK. (2017). A path to precision in the ICU. Critical Care (Impact factor: 4.950), 21(1), 79. (Article publié).
  • Rochwerg B, Hylands M*, Møller M, Asfar P, Cohen D, Khadaroo RG, Laake JH, Perner A, Tanguay T, Widder S, Vandvik P, Kristiansen A, Lamontagne F. (2017). CCCS-SSAI WikiRecs Clinical Practice Guideline: vasopressor blood pressure targets in critically ill adults with hypotension. Can J Anaesth. (Impact factor: 3.377), 64(7), 763-765. (Article publié).
  • Rochwerg B, Hylands M*, Møller M, Asfar P, Cohen D, Khadaroo RG, Laake JH, Perner A, Tanguay T, Widder S, Vandvik P, Kristiansen A, Lamontagne F. (2017). CCCS-SSAI WikiRecs Clinical Practice Guideline: vasopressors in early traumatic shock. Can J Anaesth (Impact factor: 3.377), 64(7), 766-768. (Article publié).
  • Rochwerg B, Hylands M*, Møller MH, Asfar P, Cohen D, Khadaroo RG, Laake JH, Perner A, Tanguay T, Widder S, Vandvik P, Kristiansen A, Lamontagne F. (2017). CCCS-SSAI WikiRecs clinical practice guideline: vasopressor blood pressure targets in critically ill adults with hypotension and vasopressor use in early traumatic shock. Intensive Care Med. (Impact factor: 10.125), 43(7), 1062-1064. (Article publié).
  • D'Aragon F, Dhanani S, Lamontagne F, Cook DJ, Burns K, Akhtar A, Chassé M, Frenette AJ, Keenan S, Lize JF, Kutsogiannis DJ, Kramer A, Hand LE, Arseneau E, Masse MH, Ribic C, Ball I, Baker A, Boyd G, Rochwerg B, Healey A, Hanna S, Guyatt GH, Meade MO; Canadian Critical Care Trials Group and the Canadian National Transplant Research Program. (2017). Canada-DONATE study protocol: a prospective national observational study of the medical management of deceased organ donors. BMJ Open (Impact factor: 2.369), 7(9), e018858. (Article publié).
  • Hylands M*, Toma A, Beaudoin N, Frenette AJ, D'Aragon F, Belley-Côté E*, Charbonney E, Møller MH, Laake JH, Vandvik PO, Siemieniuk RA, Rochwerg B, Lauzier F, Green RS, Ball I, Scales D, Murthy S, Kwong JSW, Guyatt G, Rizoli S, Asfar P, Lamontagne F. (2017). Early vasopressor use following traumatic injury: a systematic review. BMJ Open (Impact factor: 2.369), 7(11), e017559. (Article publié).
  • D’Aragon F, Belley Cote E*, Argarwal A, Frenette AJ, Lamontagne F, Guyatt G, Dhanani S, Meade M. (2017). Effect of Corticosteroid Administration on Neurologically Deceased Organ Donors and Transplant Recipients : A Systematic Review and Meta Analysis. BMJ Open (Impact factor: 2.369), 7(6), e014436. (Article publié).
  • Rochwerg B, Millen T, Austin P, Zeller M, D'Aragon F, Jaeschke R, Masse MH*, Mehta S, Lamontagne F, Meade M, Guyatt G, Cook DJ; Canadian Critical Care Trials Group. (2017). Fluids in Sepsis and Septic Shock (FISSH): protocol for a pilot randomised controlled trial. BMJ Open (Impact factor: 2.369), 7(7), e017602. (Article publié).
  • Duan EH, Adhikari NK, D'Aragon F, Cook DJ, Mehta S, Alhazzani W, Goligher E, Charbonney E, Arabi YM, Karachi T, Turgeon AF, Hand L, Zhou Q, Austin P, Friedrich J, Lamontagne F, Lauzier F, Patel R, Muscedere J, Hall R, Aslanian P, Piraino T, Albert M, Bagshaw SM, Jacka M, Wood G, Henderson W, Dorscheid D, Ferguson ND, Meade MO; Canadian Critical Care Trials Group. (2017). Management of ARDS and Refractory Hypoxemia: A Multicenter Observational Study. Ann Am Thorac Soc.)Impact factor: 6.9), 14(12), 1818-1826. (Article publié).
  • Lamontagne F, Marshall JC, Adhikari NKJ. (2017). Permissive hypotension during shock resuscitation: equipoise in all patients?. Intensive Care Med. (Impact factor: 10.125), 44(1), 87-90. (Article publié).
  • Schandelmaier S, Tomonaga Y, Bassler D, Meerpohl JJ, von Elm E, You JJ, Bluemle A, Lamontagne F, Saccilotto R, Amstutz A, Bengough T, Stegert M, Olu KK, Tikkinen KAO, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Busse JW, Ferreira-González I, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Guyatt G, Bucher HC, Kasenda B, Briel M. (2017). Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study. J Pediatr. (Impact factor: 3.890), 184, 209-214. (Article publié).
  • Lauzier F, Adhikari NK, Seely A, Koo KKY, Belley-Côté EP*, Burns KEA, Cook DJ, D'Aragon F, Rochwerg B, Kho ME, Oczkowksi SJW, Duan EH, Meade MO, Day AG, Lamontagne F; for ACCADEMY (Academy of Critical Care – Development, Evaluation, and Methodology). (2017). Protocol adherence for continuously titrated interventions in randomized trials: an overview of the current methodology and case study. BMC Med Res Methodol. (Impact factor: 2.524), 17(1), 106. (Article publié).
  • Simpson N, Lamontagne F, Shankar-Hari M. (2017). Septic shock resuscitation in the first hour. Curr Opin Crit Care. (Impact factor: 3.316), 23(6), 561-566. (Article publié).
  • Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, Timsit JF, Marshall JC, Myburgh J, Shankar-Hari M, Singer M. (2017). The intensive care medicine research agenda on septic shock. Intensive Care Med. (Impact factor: 10.125), 43(9), 1294-1305. (Article publié).
  • Maas AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, Bragge P, Brazinova A, Büki A, Chesnut RM, Citerio G, Coburn M, Cooper DJ, Crowder AT, Czeiter E, Czosnyka M, Diaz-Arrastia R, Dreier JP, Duhaime AC, Ercole A, van Essen TA, Feigin VL, Gao G, Giacino J, Gonzalez-Lara LE, Gruen RL, Gupta D, Hartings JA, Hill S, Jiang JY, Ketharanathan N, Kompanje EJO, Lanyon L, Laureys S, Lecky F, Levin H, Lingsma HF, Maegele M, Majdan M, Manley G, Marsteller J, Mascia L, McFadyen C, Mondello S, Newcombe V, Palotie A, Parizel PM, Peul W, Piercy J, Polinder S, Puybasset L, Rasmussen TE, Rossaint R, Smielewski P, Söderberg J, Stanworth SJ, Stein MB, von Steinbüchel N, Stewart W, Steyerberg EW, Stocchetti N, Synnot A, Te Ao B, Tenovuo O, Theadom A, Tibboel D, Videtta W, Wang KKW, Williams WH, Wilson L, Yaffe K; InTBIR Participants and Investigators. [Includes Lamontagne F]. (2017). Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. (Impact factor: 26.284), 16(12), 987-1048. (Article publié).
  • Lamontagne F, Cook DJ, Meade MO, Seely A, Day AG, Charbonney E, Serri K, Skrobik Y, Hebert P, St-Arnaud C*, Quiroz-Martinez H, Mayette M, Heyland DK. (2017). Vasopressor Use for Severe Hypotension-A Multicentre Prospective Observational Study. PLoS One (Impact factor: 3.057), 12(1), e0167840. (Article publié).
  • Hylands M*, Godbout MP, Mayer SK, Fraser WD, Vanasse A, Leclair MA, Turgeon AF, Lauzier F, Charbonney E, Trottier V, Razek TS, Roy A, D'Aragon F, Belley-Côté E*, Day AG, Le Guillan S, Sabbagh R, Lamontagne F. (2017). Vasopressor use following traumatic injury - A single center retrospective study. PLoS One (Impact factor: 3.234), 12(4), e0176587. (Article publié).
  • Hylands M*, Toma A, Beaudoin N*, Frenette AJ, D'Aragon F, Belley-Côté E*, Hylander M, Lauzier F, Siemieniuk RA, Charbonney E, Kwong J, Laake JH, Guyatt G, Vandvik PO, Rochwerg B, Green R, Ball I, Scales D, Murthy S, Rizoli S, Asfar P, Lamontagne F. (2017). Vasopressor use following traumatic injury: protocol for a systematic review. BMJ Open (Impact factor: 2.369), 7(2), e014166. (Article publié).
  • Lamontagne F, Harrison DA, Rowan K. (2017). qSOFA for Identifying Sepsis Among Patients With Infection. JAMA (Impact factor: 37.7), 317(3), 267-268. (Article publié).
  • Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M. (2016). Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials. PLoS Medicine (Impact factor: 10.35), 13(6), e1002046. (Article publié).
  • Stegert M, Kasenda B, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Briel M; DISCO study group (includes Lamontagne F). (2016). An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules. Journal of Clinical Epidemiology (Impact factor: 4.703), 69, 152-160. (Article publié).
  • Irislimane M, Lamontagne F, You JJ, Heyland DK, Brazeau-Lamontagne L. (2016). Assessing the Impact of Diagnostic Imaging at the End of Life: A Single-Center Retrospective Cohort Study. Journal of Palliative Care & Medicine (Impact factor: 0.697), 6(5), N/A. (Article publié).
  • Duan E, Oczkowski S, Belley-Côté E*, Whitlock R, Lamontagne F, Philip J, Cook D. (2016). Beta-blockers in sepsis: Protocol for a systematic review and meta-analysis of randomized control trials. BMJ Open (Impact factor: 2.562), 6(6), e012466. (Article publié).
  • Daneman N, Rishu AH, Xiong W, Bagshaw SM, Dodek P, Hall R, Kumar A, Lamontagne F, Lauzier F, Marshall J, Martin CM, McIntyre L, Muscedere J, Reynolds S, Stelfox HT, Cook DJ, Fowler RA; Canadian Critical Care Trials Group. (2016). Duration of Antimicrobial Treatment for Bacteremia in Canadian Critically Ill Patients. Critical Care Medicine (Impact factor: 7.442), 44(2), 256-264. (Article publié).
  • Koo KKY, Choong K, Cook DJ, Herridge M, Newman A, Lo V, Guyatt G, Priestap F, Campbell E, Burns KAE, Lamontagne F, Meade MO, the Canadian Critical Care Trials Group. (2016). Early mobilization of critically ill adults: a survey of knowledge, perceptions and practices of Canadian physicians and physiotherapists. CMAJ Open, 4(3), E448-E454. (Article publié).
  • Leligdowicz A, Fischer WA II, Fletcher T, Neill KJA, Portella G, Lamontagne F, M. Uyeki T, Clement C, Jacob ST, Rubinson L, Vanderschuren A, Hajek J, Murthy S, Ferri M, Crozier I, Ibrahima Bah E, Lamah MC, Schieffelin J, Brett-Major D, G. Bausch D, Shindo N, K. Chan A, O’Dempsey T, Mishra S, Jacobs M, Dickson S, G. Lyon III GM, Fowler R. (2016). Ebola virus disease and critical illness. Critical Care (Impact factor: 4.950), 20(1), 217. (Article publié).
  • Lamontagne F, Meade MO, Hébert PC, Asfar P, Lauzier F, Seely AJ, Day AG, Mehta S, Muscedere J, Bagshaw SM, Ferguson ND, Cook DJ, Kanji S, Turgeon AF, Herridge MS, Subramanian S, Lacroix J, Adhikari NK, Scales DC, Fox-Robichaud A, Skrobik Y, Whitlock RP, Green RS, Koo KK, Tanguay T, Magder S, Heyland DK; Canadian Critical Care Trials Group. (2016). Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Medicine (Impact factor: 10.125), 42(4), 542-550. (Article publié).
  • Cameron JI, Chu LM, Matte A, Tomlinson G, Chan L, Thomas C, Friedrich JO, Mehta S, Lamontagne F, Levasseur M, Ferguson ND, Adhikari NK, Rudkowski JC, Meggison H, Skrobik Y, Flannery J, Bayley M, Batt J, dos Santos C, Abbey SE, Tan A, Lo V, Mathur S, Parotto M, Morris D, Flockhart L, Fan E, Lee CM, Wilcox ME, Ayas N, Choong K, Fowler R, Scales DC, Sinuff T, Cuthbertson BH, Rose L, Robles P, Burns S, Cypel M, Singer L, Chaparro C, Chow CW, Keshavjee S, Brochard L, Hébert P, Slutsky AS, Marshall JC, Cook D, Herridge MS; RECOVER Program Investigators (Phase 1: towards RECOVER); Canadian Critical Care Trials Group. (2016). One-Year Outcomes in Caregivers of Critically Ill Patients. New England Journal of Medicine (Impact factor: 59.558), 374(19), 1831-1841. (Article publié).
  • Savage RD, Fowler RA, Rishu AH, Bagshaw SM, Cook D, Dodek P, Hall R, Kumar A, Lamontagne F, Lauzier F, Marshall J, Martin CM, McIntyre L, Muscedere J, Reynolds S, Stelfox HT, Daneman N. (2016). Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study. CMAJ Open (Impact factor: 6.8), 4(4), E569-E577. (Article publié).
  • Williamson DR, Frenette AJ, Burry L, Perreault MM, Charbonney E, Lamontagne F, Potvin MJ, Giguère JF, Mehta S, Bernard F. (2016). Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysis. Systematic Reviews (Impact factor: 1.574), 5(1), 193. (Article publié).
  • Mercier E, Boutin A, Shemilt M, Lauzier F, Zarychanski R, Fergusson D, Moore L, McIntyre L, Archambault P, Legaré F, Rousseau F, Lamontagne F, Nadeau L, Turgeon A. (2016). Predictive value of the neuron-specific enolase (NSE) for prognosis in patient with moderate of severe traumatic brain injury: a systematic review and meta-analysis. CMAJ Open, 4(3), E371-E382. (Article publié).
  • Schandelmaier S, von Elm E, You JJ, Blümle A, Tomonaga Y, Lamontagne F, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Cook DJ, Meade MO, Bucher HC, Kasenda B, Briel M. (2016). Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study. Critical Care Medicine (Impact factor: 7.442), 44(1), 130-137. (Article publié).
  • Muscedere J,Maslove D, Boyd JG, O'Callaghan N, Lamontagne F, Reynolds S, Albert M, Hall R, McGolrick D, Jiang X, Day AG. (2016). Prevention of nosocomial infections in critically ill patients with lactoferrin (PREVAIL study): study protocol for a randomized controlled trial. Trials (Impact factor: 1.859), 17(1), 174. (Article publié).
  • Savage RD, Fowler RA, Rishu AH, Bagshaw SM, Cook D, Dodek P, Hall R, Kumar A, Lamontagne F, Lauzier F, Marshall J, Martin CM, McIntyre L, Muscedere J, Reynolds S, Stelfox HT, Daneman N. (2016). The Effect of Inadequate Initial Empiric Antimicrobial Treatment on Mortality in Critically Ill Patients with Bloodstream Infections: A Multi-Centre Retrospective Cohort Study. PLoS One (Impact factor: 3.54), 11(5), e0154944. (Article publié).
  • Herridge MS, Chu LM, Matte A, Tomlinson G, Chan L, Thomas C, Friedrich JO, Mehta S, Lamontagne F, Levasseur M, Ferguson ND, Adhikari NK, Rudkowski JC, Meggison H, Skrobik Y, Flannery J, Bayley M, Batt J, Dos Santos C, Abbey SE, Tan A, Lo V, Mathur S, Parotto M, Morris D, Flockhart L, Fan E, Lee CM, Wilcox ME, Ayas N, Choong K, Fowler R, Scales DC, Sinuff T, Cuthbertson BH, Rose L, Robles P, Burns S, Cypel M, Singer L, Chaparro C, Chow CW, Keshavjee S, Brochard L, Hebert P, Slutsky AS, Marshall JC, Cook D, Cameron JI; RECOVER Program Investigators (Phase 1: towards RECOVER) and the Canadian Critical Care Trials Group. (2016). The RECOVER Program: Disability Risk Groups & One Year Outcome after ? 7 Days of Mechanical Ventilation. Am J Respir Crit Care Med (Impact factor: 13.118), 194(7), 831-844. (Article publié).
  • Honarmand K, Belley-Côté EP*, Ulic D, Khalifa A, Gibson A, McClure G, Savija N, Alshamsi F, D’Aragon F*, Rochwerg B, Duan EH, Karachi T, Lamontagne F, Devreaux PJ, Whithlock R, Cook DJ. (2016). The deferred consent model in a low risk study evaluating myocardial injury in the intensive care unit. Journal of Intensive Care (Impact factor: 3.262), N/A(N/A), 1-6. (Article publié).
  • Delaney JW, Pinto R, Long J, Lamontagne F, Adhikari NK, Kumar A, Marshall JC, Cook DJ, Jouvet P, Ferguson ND, Griesdale D, Burry LD, Burns KE, Hutchison J, Mehta S, Menon K, Fowler RA; Canadian Critical Care Trials Group H1N1 Collaborative. (2016). The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness. Critical Care (Impact factor: 4.950), 20(1), 75. (Article publié).
  • Lamontagne F, Cohen D, Herridge M. (2016). Understanding patient-centredness: contrasting expert versus patient perspectives on vasopressor therapy for shock. Intensive Care Med (Impact factor: 10.125), 43(7), 1052-1054. (Article publié).
  • Bagshaw SM, Lamontagne F, Joannidis M, Wald R. (2016). When to Start Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury: Comment on AKIKI and ELAIN. Critical Care (Impact factor: 4.950), 20(1), 245. (Article publié).
  • Lacroix J, Hébert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, Clayton L, McIntyre L, Callum J, Turgeon AF, Blajchman MA, Walsh TS, Stanworth SJ, Campbell H, Capellier G, Tiberghien P, Bardiaux L, van de Watering L, van der Meer NJ, Sabri E, Vo D; ABLE Investigators; Canadian Critical Care Trials Group [Include Lamontagne F]. (2015). Age of transfused blood in critically ill adults. New England Journal of Medicine (Impact factor: 59.558), 372(15), 1410-1418. (Article publié).
  • Daneman N, Rishu AH, Xiong W, Bagshaw SM, Cook DJ, Dodek P, Hall R, Kumar A, Lamontagne F, Lauzier F, Marshall JC, Martin CM, McIntyre L, Muscedere J, Reynolds S, Stelfox HT, Fowler RA; Canadian Critical Care Trials Group. (2015). Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial. Trials journal (Impact factor: 1.859), 16(1), 173. (Article publié).
  • You JJ, Downar J, Fowler RA, Lamontagne F, Ma IW, Jayaraman D, Kryworuchko J, Strachan PH, Ilan R, Nijjar AP, Neary J, Shik J, Brazil K, Patel A, Wiebe K, Albert M, Palepu A, Nouvet E, des Ordons AR, Sharma N, Abdul-Razzak A, Jiang X, Day A, Heyland DK. for the Canadian Researchers at the End of Life Network (CARENET). (2015). Barriers to Goals of Care Discussions With Seriously Ill Hospitalized Patients and Their Families: A Multicenter Survey of Clinicians. JAMA Intern Med (Erratum in: JAMA Intern Med. 2015 Apr;175(4):659) (Impact factor: 14), 175(4), 549-556. (Article publié).
  • Brett-Major DM, Jacob ST, Jacquerioz FA, Risi GF, Fischer WA, Kato Y, Houlihan CF, Crozier I, Bosa HK, Lawler JV, Adachi T, Hurley SK, Berry LE, Carlson JC, Button TC, McClellan SL, Shea BJ, Kuniyoshi GG, Ferri M, Murthy SG, Petrosillo N, Lamontagne F, Porembka DT, Schieffelin J, Rubinson L, O'Dempsey T, Donovan SM, Bausch DG, Fowler RA, Fletcher TE. (2015). Being Ready to Treat Ebola Virus Disease Patients. American Journal of Tropical Medicine and Hygiene (Impact factor: 2.453), 92(2), 233-237. (Article publié).
  • D'Aragon F*, Belley-Côté E*, Meade M, Lauzier F, Adhikari N, Briel M, Lalu M, Kanji S, Asfar P, Turgeon A, Fox-Robichaud A, Marshall J, Lamontagne F. (2015). Blood pressure targets for vasopressor therapy - A systematic review. Shock (Impact factor: 3.048), 43(6), 530-539. (Article publié).
  • Bah EI, Lamah MC, Fletcher T, Jacob ST, Brett-Major DM, Sall AA, Shindo N, Fischer WA 2nd, Lamontagne F, Saliou SM, Bausch DG, Moumié B, Jagatic T, Sprecher A, Lawler JV, Mayet T, Jacquerioz FA, Méndez Baggi MF, Vallenas C, Clement C, Mardel S, Faye O, Faye O, Soropogui B, Magassouba N, Koivogui L, Pinto R, Fowler RA. (2015). Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea. New England Journal of Medicine (Impact factor: 59.558), 372(1), 40-47. (Article publié).
  • Wald R, Adhikari NK, Smith OM, Weir MA, Pope K, Cohen A, Thorpe K, McIntyre L, Lamontagne F, Soth M, Herridge M, Lapinsky S, Clark E, Garg AX, Hiremath S, Klein D, Mazer CD, Richardson RM, Wilcox ME, Friedrich JO, Burns KE, Bagshaw SM. (2015). Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney International (Impact factor: 7.683), 88(4), 897-904. (Article publié).
  • Li G, Cook DJ, Levine MA, Guyatt G, Crowther M, Heels-Ansdell D, Holbrook A, Lamontagne F, Walter SD, Ferguson ND, Finfer S, Arabi YM, Bellomo R, Cooper DJ, Thabane L. (2015). Competing risk analysis for evaluation of dalteparin versus unfractionated heparin for venous thromboembolism in medical-surgical critically ill patients. Medicine (Baltimore) (Impact factor: 2.133), 94(36), e:1479. (Article publié).
  • Yale P*, Adhikari NKJ, Masse V*, Fowler RA, Xiong W, McGeer A, Can D, Rudnick W, Green K, Meade M, Valiquette L, Lamontagne F. (2015). Corticosteroid therapy in critical illness due to seasonal and pandemic influenza. Canadian Respiratory Journal (Impact factor: 1.016), 22(5), 271-274. (Article publié).
  • Fowler RA, Abdelmalik P, Wood G, Foster D, Gibney N, Bandrauk N, Turgeon AF, Lamontagne F, Kumar A, Zarychanski R, Green R, Bagshaw SM, Stelfox HT, Foster R, Dodek P, Shaw S, Granton J, Lawless B, Hill A, Rose L, Adhikari NK, Scales DC, Cook DJ, Marshall JC, Martin C, Jouvet P; Canadian Critical Care Trials Group. (2015). Critical care capacity in Canada: results of a national cross-sectional study. Critical Care (Impact factor: 4.950), 19(1), 133. (Article publié).
  • Murthy S; Ebola Clinical Care authors group [Include Lamontagne F]. (2015). Ebola and provision of critical care. Lancet (Impact factor: 44.002), 385(9976), 1392-1393. (Article publié).
  • Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, Dodek P, McIntyre L, Hall R, Heels-Ansdell D, Fowler R, Pai M, Guyatt G, Crowther MA, Warkentin TE, Devereaux PJ, Walter SD, Muscedere J, Herridge M, Turgeon AF, Geerts W, Finfer S, Jacka M, Berwanger O, Ostermann M, Qushmaq I, Friedrich JO, Cook DJ; PROphylaxis for ThromboEmbolism in Critical Care Trial Investigators. (2015). Failure of Anticoagulant Thromboprophylaxis: Risk Factors in Medical-Surgical Critically Ill Patients. Critical Care Medicine (Impact Médicine: 7.442), 43(2), 401-410. (Article publié).
  • Choong K, Al-Harbi S, Siu K, Wong K, Cheng J, Baird B, Pogorzelski D, Timmons B, Gorter JW, Thabane L, Khetani M; Canadian Critical Care Trials Group [Include Lamontagne F]. (2015). Functional recovery following critical illness in children: the "wee-cover" pilot study. Pediatric Critical Care Medicine (Impact factor: 2.659), 16(4), 310-318. (Article publié).
  • Archambault PM, Turgeon AF, Witteman HO, Lauzier F, Moore L, Lamontagne F, Horsley T, Gagnon MP, Droit A, Weiss M, Tremblay S, Lachaine J, Le Sage N, Émond M, Berthelot S, Plaisance A, Lapointe J, Razek T, van de Belt TH, Brand K, Bérubé M, Clément J, Grajales Iii FJ, Eysenbach G, Kuziemsky C, Friedman D, Lang E, Muscedere J, Rizoli S, Roberts DJ, Scales DC, Sinuff T, Stelfox HT, Gagnon I, Chabot C, Grenier R, Légaré F; Canadian Critical Care Trials Group. (2015). Implementation and Evaluation of a Wiki Involving Multiple Stakeholders Including Patients in the Promotion of Best Practices in Trauma Care: The WikiTrauma Interrupted Time Series Protocol. JMIR Research Protocol (Impact factor: 4.7), 4(1), e21. (Article publié).
  • Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J, Paparella D, Sessler DI, Karthikeyan G, Villar JC, Zuo Y, Avezum Á, Quantz M, Tagarakis GI,Shah PJ, Abbasi SH, Zheng H, Pettit S, Chrolavicius S, Yusuf S; SIRS Investigators (Includes Lamontagne F). (2015). Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet (Impact factor: 44.002), 386(10000), 1243-1253. (Article publié).
  • Downar J, You JJ, Bagshaw SM, Golan E, Sridhar SK, Burns K, Seely A, Meade MO, Fox-Robichaud A, Cook DJ, Lamontagne F, Turgeon A, Dodek PE, Fowler R. (2015). Nonbeneficial Treatment in Canada: Definitions, Causes, and Potential Solutions from the Perspective of Healthcare Practitioners. Critical Care Medicine (Impact factor: 7.442), 43(2), 270-281. (Article publié).
  • Schandelmaier S, Conen K, von Elm E, You JJ, Blümle A, Tomonaga Y, Saccilotto, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Sun X, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M, Kasenda B; DISCO study group. (2015). Planning and reporting of quality-of-life outcomes in cancer trials. Annals of Oncology (Erratum in: Ann Oncol. 2016 Jan;27(1):209; PMID: 26612098) (Impact factor 9.269), 26(9), 1966-1973. (Article publié).
  • Buchner DL, Bagshaw SM, Dodek P, Forster AJ, Fowler RA, Lamontagne F, Turgeon AF, Potestio M, Stelfox HT. (2015). Prospective cohort study protocol to describe the transfer of patients from intensive care units to hospital wards. BMJ Open (Impact factor: 2.413), 5(7), e007913. (Article publié).
  • Choong K, Foster G, Fraser DD, Hutchison JS, Joffe AR, Jouvet PA, Menon K, Pullenayegum E, Ward RE; Canadian Critical Care Trials Group [Include Lamontagne F]. (2014). Acute rehabilitation practices in critically ill children: a multicenter study. Pediatric Critical Care Medicine (Impact factor: 2.659), 15(6), e270-e279. (Article publié).
  • Fowler RA, Fletcher T, Fischer Ii WA, Lamontagne F, Jacob S, Brett-Major D, Lawler JV, Jacquerioz FA, Houlihan C, O'Dempsey T, Ferri M, Adachi T, Lamah MC, Bah EI, Mayet T, Schieffelin J, McLellan SL, Senga M, Kato Y, Clement C, Mardel S, Vallenas Bejar De Villar RC, Shindo N, Bausch D. (2014). Caring for Critically Ill Patients with Ebola Virus Disease: Perspectives from West Africa. American Journal of Respiratory and Critical Care Medicine (Impact factor: 13.204), 190(7), 733-737. (Article publié).
  • Lauzier F , Turgeon AF , Boutin A , Shemilt M , Côté I , Lachance O , Archambault PM , Lamontagne F , Moore L , Bernard F , Gagnon C , Cook D. (2014). Clinical outcomes, predictors, and prevalence of anterior pituitary disorders following traumatic brain injury: a systematic review. Critical Care Medicine (Impact factor: 3.80), 42(3), 712-721. (Article publié).
  • Rosenthal R, Kasenda B, Dell-Kuster S, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla S, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Olu KK, Raatz H, Moja L, Ebrahim S, Schandelmaier S, Sun X, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M. (2014). Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical Study. Annals of Surgery (Impact factor: 1.64), 262(1), 68-73. (Article publié).
  • Mueller KF, Briel M, Strech D, Meerpohl JJ, Lang B, Motschall E, Gloy V, Lamontagne F, Bassler D. (2014). Dissemination bias in systematic reviews of animal research: a systematic review. PLoS One (Impact factor: 3.54), 9(12), e116016. (Article publié).
  • Lamontagne F, Clément C, Fletcher T, Jacob ST, Fischer WA 2nd, Fowler RA. (2014). Doing Today's Work Superbly Well - Treating Ebola with Current Tools. New England Journal of Medicine (Impact factor: 59.558), 371(17), 1565-1566. (Article publié).
  • Crowther M, Cook D, Guyatt G, Zytaruk N, McDonald E, Williamson D, Albert M, Dodek P, Finfer S, Vallance S, Heels-Ansdell D, McIntyre L, Mehta S, Lamontagne F, Muscedere J, Jacka M, Lesur O, Kutsiogiannis J, Friedrich J, Klinger JR, Qushmaq I, Burry L, Khwaja K, Sheppard JA, Warkentin TE; PROTECT collaborators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group. (2014). Heparin Induced Thrombocytopenia in the Critically III: Interpreting the 4Ts Test in a Randomized Trial. Journal of Critical Care (Impact factor: 2.445), 29(3), 470.e7-470.e15. (Article publié).
  • Lamontagne F, McIntyre L, Dodek P, Heels-Ansdell D, Meade M, Pemberton J, Skrobik Y, Seppelt I, Vlahakis NE, Muscedere J, Reece G, Ostermann M, Padayachee S, Alhashemi J, Walsh M, Lewis B, Schiff D, Moody A, Zytaruk N, Leblanc M, Cook DJ; Prophylaxis for Thromboembolism in Critical Care Trial Investigators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group. (2014). Non-Leg Venous Thrombosis in Critically Ill Adults: A Nested Prospective Cohort Study. JAMA Internal Medicine (Impact factor: 14), 174(5), 689-696. (Article publié).
  • Kasenda B, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Schandelmaier S, Xin S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M. (2014). Prevalence, characteristics, and publication of discontinued randomized trials. JAMA (Impact factor: 37.684), 311(10), 1045-1051. (Article publié).
  • Whitlock R , Healey J , Vincent J , Brady K , Teoh K , Royse A , Shah P , Guo Y , Alings M , Folkeringa RJ , Paparella D , Colli A , Meyer SR , Legare JF , Lamontagne F , Reents W , Böning A , Connolly S. (2014). Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. Annals of Cardiothoracic Surgery (Impact factor: 2.895), 3(1), 45-54. (Article publié).
  • Garg AX, Vincent J, Cuerden M, Parikh C, Devereaux PJ, Teoh K, Yusuf S, Hildebrand A, Lamy A, Zuo Y, Sessler DI, Shah P, Abbasi SH, Quantz M, Yared JP, Noiseux N, Tagarakis G, Rochon A, Pogue J, Walsh M, Chan MT, Lamontagne F, Salehiomran A, Whitlock R; SIRS Investigators. (2014). Steroids In caRdiac Surgery (SIRS) trial: acute kidney injury substudy protocol of an international randomised controlled trial. BMJ open (Impact factor: 2.413), 4(3), e004842. (Article publié).
  • Kasenda B, Schandelmaier S, Sun X, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M; DISCO Study Group. (2014). Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications. BMJ (Erratum in: BMJ. 2014;349:g4921) (Impact factor: 4.70), 349(1), g4539. (Article publié).
  • Lauzier F, Muscedere J, Deland E, Kutsogiannis DJ, Jacka M, Heels-Ansdell D, Crowther M, Cartin-Ceba R, Cox MJ, Zytaruk N, Foster D, Sinuff T, Clarke F, Thompson P, Hanna S, Cook D; Co-operative Network of Critical Care Knowledge Translation for Thromboprophylaxis (CONECCKT-T) Investigators [Include Lamontagne F]; Canadian Critical Care Trials Group. (2014). Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit. Critical Care (Impact factor: 4.16), 18(2), R82. (Article publié).
  • Koczmara CK, St-Arnaud C*, Martinez HQ, Adhikari NK, Meade M, Bérard D, Leclair MA, Hyland S, Côté L, Torres E, Fontaine L, Béland F, Martel A, Samson S, Dubreuil J, Lagueux G, Lamarre P, Langevin C, Lamontagne F. (2014). Vasopressor stewardship: a case report and lessons shared. Dynamics (Impact factor: 2.376), 25(1), 26-29. (Article publié).
  • You JJ, Dodek P, Lamontagne F, Downar J, Sinuff T, Jiang X, Day AG, Heyland DK; ACCEPT Study Team and the Canadian Researchers at the End of Life Network (CARENET). (2014). What really matters in end-of-life discussions? Perspectives of patients in hospital with serious illness and their families. CMAJ (Impact factor: 6.7), 186(18), E679-E687. (Article publié).
  • Bagshaw SM, Sood MM, Long J, Fowler RA, Adhikari NK; Canadian Critical Care Trials Group H1N1 Collaborative [Include Lamontagne F]. (2013). Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study. BMC Nephrology (Impact factor: 2.289), 14, 123. (Article publié).
  • Meade MO , Lamontagne F. (2013). Clinical trial design in acute lung injury-issues and controversies. Seminars in Respiratory Critical Care Medicine (Impact factor: 2.274), 34(4), 516-521. (Article publié).
  • Cook D, McDonald E, Smith O, Zytaruk N, Heels-Ansdell D, Watpool I, McArdle T, Matte A, Clarke F, Vallance S, Finfer S, Galt P, Crozier T, Fowler R, Arabi Y, Woolfe C, Orford N, Hall R, Adhikari NK, Ferland MC, Marshall J, Meade M; PROTECT Research Coordinators; PROTECT Investigators; Canadian Critical Care Trials Group [Include Lamontagne F]; Australian and New Zealand Intensive Care Society Clinical Trials Group. (2013). Co-enrollment of critically ill patients into multiple studies: patterns, predictors and consequences. Critical Care (Impact factor: 4.16), 17(1), R1. (Article publié).
  • Lamontagne F, Brower R, Meade M. (2013). Corticosteroid therapy in acute respiratory distress syndrome. CMAJ (Impact factor: 6.7), 185(3), 216-221. (Article publié).
  • Lamontagne F , Quiroz Martinez H , Adhikari NK , Cook DJ , Koo KK , Lauzier F , Turgeon AF , Kho ME , Burns KE , Chant C , Fowler R , Douglas I , Poulin Y , Choong K , Ferguson ND , Meade MO. (2013). Corticosteroid use in the intensive care unit: a survey of intensivists. Canadian Journal of Anesthesia (Impact factor: 2.139), 60(7), 652-659. (Article publié).
  • Heyland DK, Barwich D, Pichora D, Dodek P, Lamontagne F, You JJ, Tayler C, Porterfield P, Sinuff T, Simon J. for the ACCEPT Study Team and the CAnadian Researchers at the End of Life NETwork (CARENET). (2013). Failure to engage hospitalized elderly patients and their families in advance care planning. JAMA Internal Medicine (Impact factor: 14), 173(9), 778-787. (Article publié).
  • Warkentin TE, Sheppard JA, Heels-Ansdell D, Marshall JC, McIntyre L, Rocha MG, Mehta S, Davies AR, Bersten AD, Crozier TM, Ernest D, Vlahakis NE, Hall RI, Wood GG, Poirier G, Crowther MA, Cook DJ; Canadian Critical Care Trials Group [Include Lamontagne F]; Australian and New Zealand Intensive Care Society Clinical Trials Group. (2013). Heparin-induced thrombocytopenia in medical surgical critical illness. Chest (Impact factor: 6.136), 144(3), 848-858. (Article publié).
  • Ferguson ND, Cook DJ, Guyatt GH, Mehta S, Hand L, Austin P, Zhou Q, Matte A, Walter SD, Lamontagne F, Granton JT, Arabi YM, Arroliga AC, Stewart TE, Slutsky AS, Meade MO; the OSCILLATE Trial Investigators and the Canadian Critical Care Trials Group. (2013). High-frequency oscillation in early acute respiratory distress syndrome. New England Journal of Medicine (Impact factor: 59.558), 368(9), 795-805. (Article publié).
  • Mercier E , Boutin A , Lauzier F , Fergusson DA , Simard JF , Zarychanski R , Moore L , McIntyre LA , Archambault P , Lamontagne F , Légaré F , Randell E , Nadeau L , Rousseau F , Turgeon AF. (2013). Predictive value of S-100? protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis. BMJ (Impact factor: 19.967), 346, f1757. (Article publié).
  • St-Arnaud C*, Éthier J-F, Hamielec C, Bersten A, Guyatt G, Meade M, Zhou Q, Leclair MA, Patel A, Lamontagne F. (2013). Prescribed targets for vasopressor titration in septic shock: a retrospective cohort study. CMAJ Open, 1(4), 127-133. (Article publié).
  • Briel M , Müller KF , Meerpohl JJ , von Elm E , Lang B , Motschall E , Gloy V , Lamontagne F, Schwarzer G , Bassler D. (2013). Publication bias in animal research: a systematic review protocol. Systematic reviews (Impact factor: 1.574), 2(23), 1-5. (Article publié).
  • Smith OM, McDonald E, Zytaruk N, Foster D, Matte A, Clarke F, Meade L, O'Callaghan N, Vallance S, Galt P, Rajbhandari D, Rocha M, Mehta S, Ferguson ND, Hall R, Fowler R, Burns K, Qushmaq I, Ostermann M, Heels-Ansdell D, Cook D; PROTECT Research Coordinators; PROTECT Investigators; Canadian Critical Care Trials Group [Include Lamontagne F]; Australian, New Zealand Intensive Care Society Clinical Trials Group. (2013). Rates and determinants of informed consent: a case study of an international thromboprophylaxis trial. Journal of Critical Care (Impact factor: 2.445), 28(1), 28-39. (Article publié).
  • Smith OM, Wald R, Adhikari NK, Pope K, Weir MA, Bagshaw SM; Canadian Critical Care Trials Group [Include Lamontagne F]. (2013). Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI): study protocol for a randomized controlled trial. Trials journal (Impact factor: 1.859), 14, 320. (Article publié).
  • Muscedere J, Ofner M, Kumar A, Long J, Lamontagne F, Cook DJ, McGeer A, Chant C, Marshall J, Jouvet P, Fowler R. for the ICU-FLU Group and the Canadian Critical Care Trials Group. (2013). The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection. Chest (Impact factor: 6.136), 144(1), 39-47. (Article publié).
  • Williamson DR, Albert M, Heels-Ansdell D, Arnold DM, Lauzier F, Zarychanski R, Crowther M, Warkentin TE, Dodek P, Cade J, Lesur O, Lim W, Fowler R, Lamontagne F, Langevin S, Freitag A, Muscedere J, Friedrich JO, Geerts W, Burry L, Alhashemi J, Cook D; PROTECT collaborators; Canadian Critical Care Trials Group; Australian and New Zealand Intensive Care Society Clinical Trials Group. (2013). Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest (Impact factor: 6.136), 144(4), 1207-1215. (Article publié).
  • Alshurafa M, Briel M, Akl EA, Haines T, Moayyedi P, Gentles SJ, Rios L, Tran C, Bhatnagar N, Lamontagne F, Walter SD, Guyatt GH. (2012). Inconsistent definitions for intention-to-treat in relation to missing outcome data: systematic review of the methods literature. PloS one (Impact factor: 3.54), 7(11), e49163. (Article publié).
  • Lamontagne F, Guyatt G. (2012). Investigator-initiated, peer-reviewed randomized controlled trials need more support. CMAJ - eLetters (Impact factor: 6.7), N/A, N/A. (Article publié).
  • Kasenda B , von Elm EB , You J , Blümle A , Tomonaga Y , Saccilotto R , Amstutz A , Bengough T , Meerpohl J , Stegert M , Tikkinen KA , Neumann I , Carrasco-Labra A , Faulhaber M , Mulla S , Mertz D , Akl EA , Bassler D , Busse J , Ferreira-González I , Lamontagne F , Nordmann A , Rosenthal R , Schandelmaier S , Sun X , Vandvik PO , Johnston BC , Walter MA , Burnand B , Schwenkglenks M , Bucher HC , Guyatt GH , Briel M. (2012). Learning from Failure - Rationale and Design for a Study about Discontinuation of Randomized Trials (DISCO study). BMC Medical Research Methodology (Impact factor: 3.059), 12(1), 131. (Article publié).
  • Akl EA , Briel M , You JJ , Sun X , Johnston BC , Busse JW , Mulla S , Lamontagne F , Bassler D , Vera C , Alshurafa M , Katsios CM , Zhou Q , Cukierman-Yaffe T , Gangji A , Mills EJ , Walter SD , Cook DJ , Schünemann HJ , Altman DG , Guyatt GH. (2012). Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ (Impact factor: 19.967), 344, e2809. (Article publié).
  • Duffett M, Burns KE, Adhikari NK, Arnold DM, Lauzier F, Kho ME, Meade MO, Hayani O, Koo K, Choong K, Lamontagne F, Zhou Q, Cook DJ. (2012). Quality of reporting of surveys in critical care journals: a methodologic review. Critical Care Medicine (Impact factor: 7.442), 40(2), 441-449. (Article publié).
  • Akl EA, Sun X, Busse JW, Johnston BC, Briel M, Mulla S, You JJ, Bassler D, Lamontagne F, Vera C, Alshurafa M, Katsios CM, Heels-Ansdell D, Zhou Q, Mills E, Guyatt GH. (2012). Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid. Journal of Clinical Epidemiology (Impact factor: 4.703), 65(3), 262-267. (Article publié).
  • Heyland, DK, Pichora D, Dodek P, Lamontagne F, You JJ, Barwich D, Tayler C, Porterfield P, Simon J, Enns B. (2012). The development and validation of a questionnaire to audit advance care planning. Journal of Palliative Care & Medicine (Impact factor: 0.697), 2(5), 119. (Article publié).
  • Duffett M , Burns KE , Kho ME , Lauzier F , Meade MO , Arnold DM , Adhikari NK , Lamontagne F , Cook DJ. (2011). Consent in critical care trials: a survey of Canadian research ethics boards and critical care researchers. Journal of Critical Care (Impact factor: 2.445), 26(5), 533.e11 – 533.e22. (Article publié).
  • Lamontagne F, Meade MO. (2011). Corticosteroids in Acute Lung Injury and Acute Respiratory Distress Syndrome. Canadian Critical Care Rounds, 8(3), 1-5. (Article publié).
  • PROTECT Investigators for the Canadian Critical Care Trials Group [Include Lamontagne F] and the Australian and New Zealand Intensive Care Society Clinical Trials Group, Cook D, Meade M, Guyatt G, Walter S, Heels-Ansdell D, Warkentin TE, Zytaruk N, Crowther M, Geerts W, Cooper DJ, Vallance S, Qushmaq I, Rocha M, Berwanger O, Vlahakis NE. (2011). Dalteparin versus unfractionated heparin in critically ill patients. New England Journal of Medicine (Impact factor: 59.558), 364(14), 1305-1314. (Article publié).
  • Adhikari N, Bashir A, Lamontagne F, Mehta S, Ferguson N, Zhou Q, Hand L, Czarnecka K, Cook D, Granton J, Friedrich J, Freitag A, Watpool I, Meade M. (2011). High frequency oscillation in adults: a retrospective cohort study. Critical Care Medicine (Impact factor: 7.442), 39(12), 2631-2644. (Article publié).
  • Lamontagne F , Cook DJ , Adhikari NK , Briel M , Duffett M , Kho ME , Burns KE , Guyatt G , Turgeon AF , Zhou Q , Meade MO. (2011). Vasopressor administration and sepsis: a survey of Canadian intensivists. Journal of Critical Care (Impact factor: 2.445), 26(5), 532.e1-7. (Article publié).
  • Choong K , Cupido C , Nelson E , Arnold DM , Burns K , Cook D , Meade M , ACCADEMY. (2010). A framework for resolving disagreement during end of life care in the critical care unit. Clinical and investigative medicine. Medecine clinique et experimentale, 33(4), E240-53. (Article publié).
  • Plamondon M , Lamontagne F , Allard C , Pépin J. (2010). Corticosteroids as adjunctive therapy in severe blastomycosis-induced acute respiratory distress syndrome in an immunosuppressed patient. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 51(1), e1-3. (Article publié).
  • Lamontagne F , Briel M , Guyatt GH , Cook DJ , Bhatnagar N , Meade M. (2010). Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials. Journal of critical care, 25(3), 420-35. (Article publié).
  • Jouvet P , Hutchison J , Pinto R , Menon K , Rodin R , Choong K , Kesselman M , Veroukis S , André Dugas M , Santschi M , Guerguerian AM , Withington D , Alsaati B , Joffe AR , Drews T , Skippen P , Rolland E , Kumar A , Fowler R , Canadian Critical Care Trials Group H1N1 Collaborative. (2010). Critical illness in children with influenza A/pH1N1 2009 infection in Canada. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 11(5), 603-9. (Article publié).
  • Freed DH , Henzler D , White CW , Fowler R , Zarychanski R , Hutchison J , Arora RC , Manji RA , Legare JF , Drews T , Veroukis S , Kesselman M , Guerguerian AM , Kumar A , Canadian Critical Care Trials Group. (2010). Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Canadian journal of anaesthesia = Journal canadien d'anesthesie, 57(3), 240-7. (Article publié).
  • Briel M , Meade M , Mercat A , Brower RG , Talmor D , Walter SD , Slutsky AS , Pullenayegum E , Zhou Q , Cook D , Brochard L , Richard JC , Lamontagne F , Bhatnagar N , Stewart TE , Guyatt G. (2010). Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA, 303(9), 865-73. (Article publié).
  • Lamontagne F , Briel M , Duffett M , Fox-Robichaud A , Cook DJ , Guyatt G , Lesur O , Meade MO. (2010). Systematic review of reviews including animal studies addressing therapeutic interventions for sepsis. Critical care medicine, 38(12), 2401-8. (Article publié).
  • Lanthier L, Lamontagne F, St-Pierre C. (2009). Complication rare d'une procédure courante: pneumomédiastin secondaire à un tube naso-gastique. Canadian Journal of General Internal Medicine, 4(2), 68-69. (Article publié).
  • Kumar A , Zarychanski R , Pinto R , Cook DJ , Marshall J , Lacroix J , Stelfox T , Bagshaw S , Choong K , Lamontagne F , Turgeon AF , Lapinsky S , Ahern SP , Smith O , Siddiqui F , Jouvet P , Khwaja K , McIntyre L , Menon K , Hutchison J , Hornstein D , Joffe A , Lauzier F , Singh J , Karachi T , Wiebe K , Olafson K , Ramsey C , Sharma S , Dodek P , Meade M , Hall R , Fowler RA , Canadian Critical Care Trials Group H1N1 Collaborative. (2009). Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA, 302(17), 1872-9. (Article publié).
  • Akl EA , Briel M , You JJ , Lamontagne F , Gangji A , Cukierman-Yaffe T , Alshurafa M , Sun X , Nerenberg KA , Johnston BC , Vera C , Mills EJ , Bassler D , Salazar A , Bhatnagar N , Busse JW , Khalid Z , Walter S , Cook DJ , Schünemann HJ , Altman DG , Guyatt GH. (2009). LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact. Trials, 10, 40. (Article publié).
  • Lamontagne F, Smieja M. (2009). Pneumococcal vaccination and myocardial infarction (Author reply). CMAJ (Impact factor: 6.7), 180, 320. (Article publié).
  • Burns KE , Duffett M , Kho ME , Meade MO , Adhikari NK , Sinuff T , Cook DJ , ACCADEMY Group. (2008). A guide for the design and conduct of self-administered surveys of clinicians. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 179(3), 245-52. (Article publié).
  • Lamontagne F, Meade M. (2008). Commentary on CORTICUS. ACP Journal (Impact factor: 5.114), 148(4), 6. (Article publié).
  • Lamontagne F , Meade MO. (2008). Low-dose hydrocortisone did not improve survival in patients with septic shock but reversed shock earlier. ACP journal club, 148(4), 6. (Article publié).
  • Lamontagne F , Meade M , Ondiveeran HK , Lesur O , Fox-Robichaud AE , Robichaud AE. (2008). Nitric oxide donors in sepsis: a systematic review of clinical and in vivo preclinical data. Shock (Augusta, Ga.), 30(6), 653-9. (Article publié).
  • Lamontagne F , Garant MP , Carvalho JC , Lanthier L , Smieja M , Pilon D. (2008). Pneumococcal vaccination and risk of myocardial infarction. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 179(8), 773-7. (Article publié).
  • Briel M, Lamontagne F. (2008). Summarizing the evidence on corticosteroids for the acute respiratory distress syndrome (ARDS) – some methodological annotations. BMJ – Rapid Responses, 336, 1-10. (Article publié).
  • Lamontagne F , Labbé AC , Haeck O , Lesur O , Lalancette M , Patino C , Leblanc M , Laverdière M , Pépin J. (2007). Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Annals of surgery, 245(2), 267-72. (Article publié).
  • Plante GE , Lamontagne F , Sirois P. (1996). [Contribution of the vascular interstitial matrix to induced contraction by angiotensin II. In vitro studies on the rabbit aorta, mesenteric artery and vein]. Archives des maladies du coeur et des vaisseaux, 89(8), 997-1001. (Article publié).

Chapitres de livre

  • Clément C, Adhikari NKJ, Lamontagne F. (2019). Evidence-Based Clinical Management of Ebola Virus Disease and Epidemic Viral Hemorrhagic Fevers. Helen W. Boucher Updates in Tropical Medicine: Infectious Disease Clinics of North America (33). États-Unis : Elsevier. (Article publié).
  • Lamontagne F, Kanji S, Tanguay T. (2018). Introduction to Circulation - Vasopressors. Pierre Cardinal, Sharon Yamashita, Tobias Witter Navigating Medical Emergencies Canada : Royal College of Physicians and Surgeons of Canada. (Article publié).
  • Lamontagne F, Meade M. (2016). Inhaled Vasodilators-Do They Make A Difference?. Neligan PJ Deutschman CS The Evidence Based Practice of Critical Care États-Unis : Saunders Elsevier. (Article publié).
  • Meade MA, Lamontagne F. (2013). Clinical Trial Design in Acute Lung Injury—Issues and Controversies. Lynch, JP Seminars in Respiratory and Critical Care Medicine (34). États-Unis : Thieme Medical Publishers. (Article publié).

Articles de journaux

  • L’Ebola peut se guérir selon le docteur François Lamontagne du CHUS (Geneviève Proulx). Ici Radio Canada.

Ressources en ligne

  • (2018). CCCTG - LOVIT. Site Web.
  • (2014). YouTube video presenting the rationale for the OVATION Trial. Site Web.
  • (2013). OVATION Pilot Trial website. Site Web.

Lignes directrices en matière de soins cliniques

  • (2021). Update to living WHO guideline on drugs for covid-19 (3). DOI.
  • Lamontagne F, Agoritsas T, Macdonald H, Leo YS, Diaz J, Agarwal A, Appiah JA, Arabi Y, Blumberg L, Calfee CS, Cao B, Cecconi M, Cooke G, Dunning J, Geduld H, Gee P, Manai H, Hui DS, Kanda S, Kawano-Do. (2020). A living WHO guideline on drugs for covid-19. DOI.
  • Rochwerg B, AgarwalA, Zeng L, Leo YS, Appiah JA, Agoritsas T, Bartoszko J, Brignardello-PetersenR, Ergan B, Ge L, Geduld H, Gershengorn HB, Manai H, Huang M, Lamontagne F, Kanda S, Kawano-DouradoL, Ku. (2020). Remdesivir for severe covid-19: a clinical practice guideline. DOI.
  • Ye Z, Rochwerg B, Wang Y, Adhikari NK, Murthy S, Lamontagne F, Fowler RA, Qiu H, Wei L, Sang L, Loeb M, Shen N, Huang M, Jiang Z, Arabi YM, Colunga-Lozano LE, Jiang L, Koh Y, Liu D, Liu F, Phua J, She. (2020). Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. DOI.
  • Siemieniuk R, Rochwerg B, Agoritsas T, Lamontagne F, Leo YS, Macdonald H, Agarwal A, Zeng L, Lytvyn L, Appiah JA, Amin W, Arabi Y, Blumberg L, Burhan E, Bausch FJ, Calfee CS, Cao B, Cecconi M, Chanda. (2020). Update to living WHO guideline on drugs for covid-19. DOI.
  • Reed Siemieniuk, Bram Rochwerg, Thomas Agoritsas, François Lamontagne, Yee-Sin Leo, Helen Macdonald, Arnav Agarwal, Linan Zeng, Lyubov Lytvyn, John Adabie Appiah, Wagdy Amin, Yaseen Arabi, Lucille Blu. (2020). Update to living WHO guideline on drugs for covid-19. (2). DOI.
  • WHO collaborators. (2020). WHO- Living guidance - Corticosteroids for COVID-19.
  • Honarmand K, Um KJ, Belley-Côté EP, Alhazzani W, Farley C, Fernando SM, Fiest K, Grey D, Hajdini E, Herridge M, Hrymak C, Møller MH, Kanji S, Lamontagne F, Lauzier F, Mehta S, Paunovic B et al. (2019). Canadian Critical Care Society clinical practice guideline: The use of vasopressin and vasopressin analogues in critically ill adults with distributive shock.
  • Rochwerg B,, Almenawer SA, Siemieniuk RAC, Vandvik PO, Agoritsas T, Lytvyn L, Alhazzani W, Archambault P, D'Aragon F, Farhoumand PD, Guyatt G, Laake JH, Beltrán-Arroyave C, McCredie V, et al. (2018). Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline.
  • Lamontagne F, Rochwerg B, Lytvyn L, Guyatt GH, Møller MH, Annane D, Kho ME, Adhikari NKJ, Machado F, Vandvik PO, Dodek P, Leboeuf R, Briel M, Hashmi M, Camsooksai J, Shankar-Hari M, et al. (2018). Corticosteroid therapy for sepsis: a clinical practice guideline.
  • Rochwerg B, Hylands M, Møller MH, Asfar P, Cohen D, Khadaroo RG, Laake JH, Perner A, Tanguay T, Widder S, Vandvik P, Kristiansen A, Lamontagne F. (2017). CCCS-SSAI WikiRecs Clinical Practice Guideline: vasopressor blood pressure targets in critically ill adults with hypotension.
  • Rochwerg B, Hylands M, Møller M, Asfar P, Cohen D, Khadaroo RG, Laake JH, Perner A, Tanguay T, Widder S, Vandvik P, Kristiansen A, Lamontagne F. (2017). CCCS-SSAI WikiRecs Clinical Practice Guideline: vasopressors in early traumatic shock.
  • Rochwerg B, Hylands M, Møller MH, Asfar P, Cohen D, Khadaroo RG, Laake JH, Perner A, Tanguay T, Widder S, Vandvik P, Kristiansen A, Lamontagne F. (2017). CCCS-SSAI WikiRecs clinical practice guideline: vasopressor blood pressure targets in critically ill adults with hypotension and vasopressor use in early traumatic shock.
  • Lamontagne F, Fowler RA, Adhikari NK, Murthy S, Brett-Major DM, Jacobs M5, Uyeki TM, Vallenas C, Norris SL, Fischer WA 2nd, Fletcher TE, Levine AC, Reed P, Bausch DG, Gove S, et al. (2017). Evidence-based guidelines for supportive care of patients with Ebola virus disease.
  • Christian M, Fowler F, Niranjan TK, Kumar A, Lamontange F, Murthy S, Wax R, Mazurik L, McEwen J, Libman M, Bogglid A, Garber G, Hota S, Keystone J, McGeer A, Vanderkooi O. (2014). Ebola Clinical Care Guidelines.
  • Adhikari NKJ, Hébert PC, Kanji S, Lamontagne F, Perri D, Quiroz-Martinez H. (2014). Improving Vasopressor Safety.

Articles de conférence

  • Burns K, Rizvi L, Seely AJ, Cook DJ, Mayette M, Tanios M, Rochwerg B, Devlin J, D'Aragon F, Lamontagne F, Sia YT, Charbonney E, Criner G, Kutsogiannis D, Hyzy R, Turgeon A, Aslanian P, J. Liebler J, Shanholtz C, Tsang J. Duan E, Meade M, Hill N for the Canadian Critical Care Trials Group. (2020). Impactof Frailty on Clinical Outcomes in the Fast Trial. 2020;201: . American Journal of Respiratory and Critical Care Medicine, A2876.
  • D’Aragon F, Burns E.A. K, Chasse M, Frenette AJ, Ball I, Rochwerg B, English S, Boyd G, Kramer A, Healey A, Dhanani S, Lauzier F, Keenan S, Wang HT, Isac G, Wood G, Breau R, Hand L, Masse MH, Ibrahim Q, Lamontagne F, Meade M on behalf of the Canadian Critical Care Trials Group and Canadian Donation and Transplantation Research Program. (2019). Association between cause of death and organ yield in organ donation after circulatory death in Canada. Canadian Critical Care Forum. (Article publié).
  • Viens I, St-Arnaud C, Battista MC, Haroune L, Masse MH, D’Aragon F, Marsault É, Boumahni D, Porteus RK, Quiroz Martinez H, Chassé M, Marchand J, Garant MP, Pinto R , Charbonney E,Wilcox E, Adhikari N, Lamontagne F. (2019). Baseline L-ascorbic acid levels in OVATION65. Critical Care Forum 2019. (Article publié).
  • D’Aragon F, Chasse M, Lamontagne F, Frenette AJ, Cook D, Ibrahim Q, Breau R, Kutsogiannis J, Shahin J, Ball I, English S, Basmaji J, Colunga-Lozano L, Hanna S, Meade M on behalf of the Canadian Critical Care Trials Group and Canadian Donation and Transplantation Research Program. (2019). Corticosteroid therapy in deceased liver donation. Canadian Critical Care Forum 2019. (Article publié).
  • Kiiza P, Mullin S, Teo K, Perez A, Piquette D, Lee J, Thompson K, Kao R, Chan A, Mishra S, Hajek J, Murthy S, Lamontagne F, Tien H, Marshall J, Simor A, Burgess R, Hall T, Christian M, Pinto R, Vanderschuren A, Goodman L, Adhikari N, Fowler R. (2019). Establishing Feasibility & Safety of Providing Critical Care for Patients withEbola through Design of a Simulated Ebola Treatment Unit. Critical Care Canada Forum 2018 (published in Can J Anesth/J Can Anesth (2019) 66(Suppl 1): 1. https://doi.org/10.1007/s12630-019-01292-0). (Article publié).
  • Haroune L, Battista MC, Saibi S, Marsault É, Adhikari Nk, Lamontagne F. (2019). Evaluation of liquid chromatography tandem mass spectrometry for plasmaascorbic acid quantification. Critical Care Forum 2019. (Article soumis).
  • Jabrane M, Adhikari N, Battista MC, Masse MH, Côté G, Garant MP, Lévesque D, Chassé M, Lebrasseur M, Watpool I, D’Aragon F, Leclair MA, Poulin Y, Grondin Beaudoin B, Bérard D, Pinto R, Wald R, Wilcox E, Carbonneau É, Boisvert FM, Lamontagne F. (2019). Urinary Biomarkers of Acute Kidney Injury in the Ovation-65 trial: ANested Analysis of the Urinary Proteome. Critical Care Forum 2019. (Article publié).
  • Rochwerg B, D’Aragon F, Zeller MP, Millen T, Austin P, Masse MH, Mehta S, Lamontagne F, Meade M, Guyatt G, Cook DJ on behalf of the Canadian Critical Care Trials Group. (2018). Fluids In Septic Shock (FISSH): A pilot randomized controlled trial. American Thoracic Society: ATS Conference 2018. (Article accepté).
  • Hamilton M, Tomlinson G, Chu L, Robles P, Matte A, Burns S, Thomas C, Lamontagne F, Adhikari N, Ferguson N, Freidrich J, Rudkowski J, Skrobik Y, Meggison H, Cameron J, Herridge M, for the RECOVER Program Investigators and the Canadian Critical Care Trials Group. (2017). Determinants of depressive symptoms at one year after intensive care unit discharge in survivors of = 7 days of mechanical ventilation: results from the recover program. American Thoracic Society International Conference. (Article publié).
  • Brown K, Leigh JP, Kamran H, Dodek PM, Bagshaw SM, Forster AJ, Turgeon AF, Fowler RA, Lamontagne F, Stelfox HT. (2017). Textual Analysis of Physician Progress Notes for Patients Transferred from the Intensive Care Unit to Hospital Ward. American Thoracic Society (ATS) Conference. (Article accepté).
  • Hylands M*, Toma A, Beaudoin N*, Frenette AJ, D'Aragon D, BelleyCôté E*, Charbonney E, Hylander M, Laake JH, Vandvik PO, Siemieniuk RA, Rochwerg B, Lauzier F, Green R, Ball I, Scales D, Murthy S, Kwong J, Guyatt G, Rizoli S, Asfar P, Lamontagne F. (2017). Utilisation de vasopresseurs en traumatologie - Revue systématique. 48e Congrès annuel 2017 – Association Québécoise de Chirurgie (AQC). (Article soumis).
  • Merman E, Chu L, Robles P, Tomlinson G, Thomas C, Burns S, Matte AA, Matte A, Friedrich J, Lamontagne F, Mehta G, Adhikari N, Ferguson N, Rudkowski J, Meggison H, Skrobik Y, Flannery J, Bayley M, Batt J, Dos Santos C, Cook D, Cameron J, Herridge MS. (2016). Burden Of Comorbid Illness Is Associated With 1-Year Survival But Not Early Disability After Critical Illness: Results From The Recover Program. American Thoracic Society International Conference (2016).Am J Respir Crit Care Med 193;2016: A1166. (Article publié).
  • D’Aragon F, Dhanani S, Arseneau E, Cook D, Ribic C, Lamontagne F, Guyatt G, Meade M for the Canada-DONATE Investigators, the Canadian Critical Care Trials Group and the Canadian National Transplant Research Program. (2016). Canada-DONATE: a National Program of Research in Deceased Organ Donation. 2016 Canadian Society of Transplantation, Canadian National Transplant Research Program and the Société Québécoise de Transplantation (CST-CNTRP-SQT). (Article publié).
  • Lai A, Zeller M, Millen T, Kavsak P, Lamontagne F, Cook D, Meade M, Rochwerg B. (2016). Chloride concentration of commonly available 5% human albumin solutions. 45th Critical Care Congress. Crit Care Med. 2016 Dec;44(12 Suppl 1):437. (Article publié).
  • Dunberry-Poissant S, Gilbert K, Baril F, Bouchard C, Hylands M*, Lamontagne F, Rousseau G, Charbonney E. (2016). Comparison Of Resuscitation With Or Without Norepinephrine In A Rat Model Of Controlled Haemorrhagic Shock. American Thoracic Society International Conference 2016. Am J Respir Crit Care Med 193;2016: A7064. (Article publié).
  • Haroune L, Battista MC, Saibi S, Marsault É, Adhikari NK, Lamontagne F. (2016). Development of a tandem mass spectrometry coupled to liquid chromatographymethod for total L-ascorbic acid quantification for use in pragmaticmulticenter clinical trials. Critical Care Forum. (Article accepté).
  • Kho ME, Duffett M, Needham DM, Herridge MS, Koo KK, Lamontagne F, Dodek PM, Costigan F, Cook D. (2016). Identifying Clinically Important Outcomes In Clinical Trials Of Neuromuscular Electrical Stimulation (nmes) In The Icu: A Survey Of Key Stakeholders. American Thoracic Society International Conference (2016). Am J Respir Crit Care Med 193;2016: A1172. (Article publié).
  • Kho ME, Duffett M, Needham DM, Herridge MS, Koo KK, Lamontagne F, Dodek PM, Costigan F, Cook D. (2016). Systematic Review Of Clinically Important Outcomes In Clinical Trials Of Neuromuscular Electrical Stimulation (nmes) In The ICU: Preliminary Results. American Thoracic Society International Conference (2016). Am J Respir Crit Care Med 193;2016: A1173. (Article publié).
  • Hylands M*, Beaudoin N*, Toma A, Frenette AJ, Kwong J, Belley-Côté E*, D'Aragon F, Lamontagne F. (2016). Target Blood Pressure for Vasopressor Therapy in Shock: A systematic review and meta-analysis. 45th Critical Care Congress. Crit Care Med. 2016 Dec;44(12 Suppl 1):160. (Article publié).
  • D’Aragon F, Lamontagne F. (2016). The DONATE-Consent Study. Canadian National Transplant Research Program and the Société Québécoise de Transplantation (CST-CNTRP-SQT). (Article accepté).
  • D'Aragon F, Yaworski A, Frenette AJ, Oczkowski S, Rochwerg B, Belley-Côté E*, Lamontagne F, Meade M. (2016). The Donate-Consent Study. 45th Critical Care Congress. Crit Care Med. 2016 Dec;44(12 Suppl 1):216. (Article publié).
  • Hylands M*, Beaudoin N*, Toma A, Frenette AJ, Kwong J, D'Aragon F, Belley-Côté E*, Lamontagne F. (2016). Vasopressor use following traumatic injury: a systematic review. 45th Critical Care Congress. Crit Care Med. 2016 Dec;44(12 Suppl 1):469. (Article publié).
  • D’Aragon F*, Agarwal A, Meade M, Belley-Côté E*, Frenette AJ, Lamontagne F, Dhanani S. (2015). Abstract-based speciality award)Effect of steroids administration on brain dead organ donors and recipients: A systematic review (. 44th Critical Care Congress: Society of Critical Care Medicine. (Article publié).
  • Nascimento B, Rizoli S, Trpcic S, Adhikari N, Lamontagne F, Cumyn A, Burns K, Scales D, Duffett M, Blair H. (2015). A national survey of canadian research ethics board practices. Trauma 2015 Annual Scientific Meeting & Conference. (Article publié).
  • Millen T, Zeller M, Kavsak P, Guyatt G, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M. (2015). Chloride concentration of IV albumin solutions available at Canadian hospitals. Canadian Critical Care Forum 2015. (Article publié).
  • Lamontagne F, Meade MO, Heyland D, Hebert P, Lauzier F, Seely A, Mehta S, Muscedere J, Kanji S, Turgeon AF, Ferguson ND, Herridge MS, Subramanian S, Cook DJ, Bagshaw SM, Adhikari N, Scales DC, Day A, Lacroix J, Fox-Robichaud A, Green R, Asfar P, Tanguay T, Koo K, Magder SA, Whilock R. (2015). The Optimal Vasopressor Titration (ovation) Pilot Randomized Controlled Trial. American Thoracic Society International Conference (2015). Am J Respir Crit Care Med 191;2015: A6418. (Article publié).
  • Herridge MS, Chu LM, Matte AL, Tomlinson G, Chan L, Thomas C, Friedrich JO, Mehta S, Lamontagne F, Levasseur M, Ferguson N, Adhikari NKJ, Rudkowski JC, Meggison H, Skrobik Y, Flannery J, Bayley M, Batt J, dos Santos C, Abbey SE, Tan A, Mathur LS, Parotto M, Flockart L, Fan E, Lee ME, Wilcox ME, Ayas N, Choon K, Fowler R, Rubenfeld GD, Scales DC, Sinuff T, Cuthbertson BH, Rose L, Robles P, Burns S, Cypel M, Singer L, Chaparro C, Chow CW, keshavjee S, Brochard L, Hebert P, Slutsky AS, Marshall J, Cook D, Cameron JI. (2015). The RECOVER Program: One-Year Disability in Critically Ill PatientsMechanically Ventilated (MV) for 7 Days. American Thoracic Society International Conference (2015). Am J Respir Crit Care Med 191;2015: A5123. (Article publié).
  • Savage R, Fowler R, Bagshaw S, Cook D, Dodek P, Hall R,Kumar A, Lamontagne F, Lauzier F, Marshall J, Martin C, Mcintyre L, Muscedere J, Reynolds S, Rishu A, Stelfox T, Daneman N. (2015). The effect of inadequate initial antimicrobial treatment on mortality in critically ill patients with bloodstream infections. IDWeek 2015. (Article publié).
  • James TE, James T, Barron C, Lamontagne F, Belley-Cote E*, Yang H, Fergusson D, D'Aragon F*, McIntyre L, Stewart D, Lalu M. (2015). The effect of vasopressor dosing on microcirculatory perfusion in preclinical animal models of sepsis: a systematic review and meta-analysis. Canadian Critical Care Forum 2015. (Article publié).
  • Hylands M*, Godbout MP, Lamontagne F. (2015). Vasopressor use following traumatic injury - a single-center historical cohort study. Society of Critical Care Medicine 44th Critical Care Congress. Crit Care Med 2015;43(12):296. (Article publié).
  • Cameron JI, Chan L, Czerwonka A, Chu LM, Matte AL, Tomlinson G, Thomas C, Ferguson ND, Mehta S, Friedrich J, Adhikari N, Fowler R, Lamontagne F, Rudkowski JC, Meggison H, Ayas N, Skrobik Y, Batt JA, dos Santos C, Flannery J, Abbey S, Rubenfeld GD, Scales DC, Sinuff T, Cuthbertson B, Fan E, Slutsky AS, Levasseur M, Bayley M, Lee C, Lo V, Mathur S, Tan A, Wilcox ME, Marshall JC, Cook DJ, Herridge MS Canadian Critical Care Trials Group. (2014). Caregiver Well-Being Is Dependent On Caregiver Mastery, Social Support And Participation In Valued Activities: Towards RECOVER Study. American Thoracic Society 2014 International Conference. Am J Respir Crit Care Med 189; 2014: A1144. (Article publié).
  • Lamontagne F, Bosma K, Adhikari N, Friedrich J, Silversides J, Sanchez J, Wise M, Arroglia A, Arabi Y, Charbonney E, Lazosky L, Granton JT, Ferguson ND, Meade MO. (2014). Changes In MAP And Vasopressors Predict Mortality In Oscillation For ARDS. Data From The OSCILLATE Trial. Am J Respir Crit Care Med, A1172. (Article publié).
  • Rishu A, Daneman N, Xiong W, Bagshaw SM, Dodek PM, Hall R, Kumar A, LamontagneF, Lauzier F, Marshall JC, McIntyre LA, Martin C, Muscedere J, Reynolds S,Stelfox HT, Fowler R. (2014). Description Of Duration Of Treatment For Bloodstream Infection In Critically Ill Patients: A Multi-Centre Observational Study. Am J Respir Crit Care Med, A2539. (Article publié).
  • D'Aragon F*, Agarwal A, Meade M, Belley-Cote E*, Frenette AJ, Lamontagne F, Dhanani S. (2014). Effect of steroids administration on brain dead organ donors and recipients: a systematic review. Canadian Critical Care Group meeting 2014. (Article publié).
  • D'Aragon F*, Agarwal A, Meade M, Belley-Cote E*, Frenette AJ, Lamontagne F, Dhanani S. (2014). Effect of steroids administration on brain dead organ donors and recipients: a systematic review. Crit Care Med, S26. (Article publié).
  • D’Aragon F*, Argawal A, Belley-Côté E*, Frenette AJ, Dhanani S, Lamontagne F, Meade M. (2014). Effect of steroids administration on organ donors after death by neurological criteria and recipients: a meta-analysis. Canadian Critical Care Forum 2014. (Article publié).
  • Herridge M, Chu LM, Matte AL, Chan L, Tomlinson G, Ferguson ND, Mehta S, Friedrich J, Adhikari N, Fowler R, Lamontagne F, Rudkowski JC, Meggison H, Skrobik Y, Batt J, dos Santos C, Flannery J, Abbey S, Rubenfeld GD, Scales D, Sinuff T, Cuthbertson B, Fan E, Slutsky AS, Levasseur M, Bayley M, Lee CM, Lo V, Mathur S, Tan A, Wilcox ME, Marshall JC, Cook DJ, Cameron JI. Canadian Critical Care Trials Group. (2014). Long-term patient outcomes after prolonged mechanical ventilation: the TOWARDS RECOVER STUDY. American Thoracic Society 2014 International Conference. Am J Respir Crit Care Med 189; 2014: A3879. (Article publié).
  • Craig J, Daneman N, Rishu A, Xiong W, Bagshaw SM, Dodek PM, Hall R, Kumar A, Lamontagne F, Lauzier F, Marshall JC, Martin C, McIntyre LA, Muscedere J, Reynolds S, Stelfox HT, Fowler R. (2014). Measuring The Duration Of Adequate Antimicrobial Treatment For Blood Stream Infections In Critically Ill Patients. American Thoracic Society 2014 International Conference. Am J Respir Crit Care Med 189;2014: A3120. (Article publié).
  • Lamontagne F, McIntyre LA, Dodek PM, Heels-Ansdell D, Meade MO, Pemberton J, Skrobik Y, Seppelt I, Vlahakis N, Muscedere J, Reece G, Ostermann M, Padayachee S, Alhashemi J, Walsh M, Lewis B, Schiff D,. (2014). Non-Leg Venous Thrombosis in Critically Ill Adults: A Nested Prospective Cohort Study. Am J Respir Crit Care Med, A1878. (Article publié).
  • Belley-Côté E*, D’Aragon F*, Meade M, Lauzier F, Adhikari N, Briel M, Lalu M, Kanji S, ASfar P, Turgeon A, Fox-Robichaud A, Marshall J, Lamontagne F. (2014). Optimal vasopressor targets in septic shock: a systematic review and meta-analysis. Canadian Critical Care Forum 2014. (Article publié).
  • Daneman N, Rishu A, Xiong W, Bagshaw SM, Dodek PM, Hall R, Kumar A, Lamontagne F, Lauzier F, Marshall JC, McIntyre LA, Martin C, Muscedere J, Reynolds S, Stelfox HT, Fowler R. (2014). Patient And Pathogen Predictors Of Antibiotic Treatment Duration For Bloodstream Infection In Critically Ill Patients. Am J Respir Crit Care Med, A3128. (Article publié).
  • Lamontagne F, Zytaruk N, Dhingra V, Lee A, Chittock D, Meade MO, Granton J, Dodek PM, McIntyre LA, Skrobik Y, Eddington J, Botha J, Evans D, Cox M, Nates J, Schiff D, Sharpe M, Heels-Ansdell D. (2014). Risk of thromboses from peripherally inserted central catheters (PICCs) in the ICU. Am J Respir Crit Care Med, A4424. (Article publié).
  • Hand L, Ferguson ND, Cook DJ, Lamontagne F, Clarke F, Matte AL, Zhou Q, Meade M. (2014). Staged Eligibility Assessments with Standardized Ventilator Settings In the OSCILLATE Trial. Am J Respir Crit Care Med, A4467. (Article publié).
  • Mehta S, Meade M, Friedrich JO, Zhou Q, Iwashyna TJ, Lamontagne F, Bosma K, Burry L, Park P, Arroliga A, for the OSCILLATE Investigators and the Canadian Critical Care Trials Group. (2014). Variation in neuromuscular blocker use in a randomized controlled trialof high-frequency oscillation. Intensive Care Medecine, S92-93. (Article publié).
  • Mehta S, Meade M, Friedrich JO, Zhou Q, Iwashyna TJ, Lamontagne F, Bosma K, Burry L, Park P, Arroliga A. (2014). Variation in neuromuscular blocker use in a randomized controlled trial of high-frequency oscillation. Intensive care medicine. Canadian Critical Care group meeting 2014. (Article publié).
  • Bourgault P, Tousignant-Laflamme L, Belzile-Lachapelle S, Gosselin E, Coleman RM, Beland F, Lamontagne F, Gelinas C. (2013). Changes in bispectral index during pain procedure compared to rest in patients unable to communicate in the ICU. 34th Annual Scientific Meeting of the Canadian Pain Society. (Article publié).
  • Ferguson ND, Cook DJ, Guyatt GH, Mehta S, Hand L, Austin P, Zhou Q, Matte AL, Walter SD, Lamontagne F, Granton JT, Arabi YM, Arroliga AC, Stewart TE, Slutsky AS, Meade MO. (2013). Early high-frequency oscillation for adults with acute respiratory distress syndrome: a randomized controlled trial. American Thoracic Society International Conference (2013). Am J Resp Crit Care Med. 2013;187: A5961. (Article publié).
  • Koo KK, Cook DJ, Lamontagne F, Campbell E, Hand L, Clarke F, Zytaruk N, McLeod A, Soucy I*, Boutin M*, Priestap F, Meade MO on behalf of the Canadian Critical Care Trials Group. (2013). Inter-rater Reliability of Observed, Stated and Documented Acute Rehabilitation in Canadian Intensive Care Units. American Thoracic Society International Conference. Am J Respir Crit Care Med. 2013;187: A5299. (Article publié).
  • Cameron JI, Chan L, Czerwonka A, Chu LM, Matte AL, Tomlinson G, Ferguson ND, Mehta S, Friedrich J, Adhikari N, Fowler R, Lamontagne F, Rudkowski J, Meggison H, Ayas N, Skrobik Y, Batt J, et al. (2013). Long-Term Outcomes After Prolonged Mechanical Ventilation: Family Caregiver Outcomes From The Towards RECOVER Study. American Thoracic Society International Conference (2013). Am J Respir Crit Care Med 187;2013: A4446. (Article publié).
  • Herridge MS, Chu LM, Matte AL, Chan L, Tomlinson G, Ferguson ND, Mehta S, Friedrich J, Adhikari N, Fowler R, Lamontagne F, Rudkowski JC, Meggison H, Ayas N, Skrobik Y, Batt J, Dos Santos C, et al. (2013). Long-Term Patient Outcomes After Prolonged Mechanical Ventilation: The Towards RECOVER Study. American Thoracic Society International Conference (2013). Am J Respir Crit Care Med 187;2013: A3623. (Article publié).
  • Asselin M, Lachance Y, Lalonde G, Boutin A, Shemilt M, Moore L, Lauzier F, Zarychanski R, Archambault P, Lamontagne F, Fergusson D, Turgeon AF. (2013). Long-term functional outcome in adults with severe TBI: a meta-analysis. 33th International Symposium on Intensive Care and Emergency Medicine. (Article publié).
  • Asselin M, Lachance Y, Lalonde G, Boutin A, Shemilt M, Moore L, Lauzier F, Zarychanski R, Archambault P, Lamontagne F, Fergusson D, Turgeon AF. (2013). Long-term functional outcome in adults with severe TBI: a meta-analysis. 33th International Symposium on Intensive Care and Emergency Médicine. Critical Care 2013; 17(Suppl2): P334. (Article publié).
  • Asselin M, Lemay-Lachance Y, Lalonde G, Boutin A, Shemilt M, Moore L, Lauzier F, Zarychanski R, Archambault P, Lamontagne F, Fergusson D, Turgeon AF. (2013). Long-term outcome in adults with severe TBI. Canadian Anesthesiologist’s Society annual meeting. (Article publié).
  • Cameron J, Chan L, Czerwonka A, Chu L, Matte A, Tomlinson G, Thomas C, Ferguson N, Mehta S, Friedrich J, Adhikari N, Fowler R, Lamontagne F, Rudkowski J, Meggison H, Ayas N, Skrobik Y, Batt J, dos Santos C, Flannery J, Abbey S, Rubenfeld G, Scales D, Sinuff T, Cuthbertson B, Fan E, Slutsky A, Levasseur M, Bayley M, Lee C, Lo V, Marthur S, Tan A, Wilcox E, Marshall J, Cook D, Herridge M. (2013). Long-term outcomes after prolonged mechanical ventilation: Family caregiver outcomes from the TOWARDS RECOVER study. Canadian Critical Care Forum 2013. (Article publié).
  • Herridge M, Chu L, Matte A, Chan L, Tomlinson G, Ferguson N, Mehta S, Friedrich J, Adhikari N, Fowler R, Lamontagne F, Rudkowski J, Meggison H, Skrobik Y, Ayas N, Batt J, dos Santos C, Flannery J, Abbey S, Rubenfeld G, Scales D, Cuthbertson B, Sinuff T, Fan E, Thomas C, Slutsky A, Levasseur M, Bayley M, Lee C, Lo V, Mathur S, Tan A, Wilcox E, Marshall J, Cook D, Cameron J. (2013). Long-term patient outcomes after prolonged mechanical ventilation: the TOWARDS RECOVER study. Canadian Critical Care Forum 2013. (Article publié).
  • Herridge M, Chu LM, Matte AL, Chan L, Tomlinson G, Ferguson ND, Mehta S, Friedrich J, Adhikari N, Fowler R, Lamontagne F, Rudkowski JC, Meggison H, Ayas N, Skrobik Y, Thomas C, Batt J, dos Santos C, Flannery J, Abbey S, Rubenfeld GD, Scales D, Sinuff T, Cuthbertson B, Fan E, Slutsky AS, Leung G, Moody A, Levasseur M, Bayley M, Lee CM, Lo V, Mathur S, Tan A, Wilcox ME, Marshall JC, Cook DJ, Cameron JI. Canadian Critical Care Trials Group and the RECOVER Investigators. (2013). Long-term patient outcomes after prolonged mechanical ventilation: the towards RECOVER study. Intensive Care Medecine, S501-502. (Article publié).
  • Kho ME, Duffett MC, Koo KK, Dodek P, Herridge MS, Lamontagne F, Needham DM, Cook DJ. (2013). Patient-important outcomes reported in randomized clinical trials (RCTs) of neuromuscular electrical stimulation in mechanically ventilated patients: A systematic methodologic review. 21st Cochrane Colloquium. Cochrane Database Syst Rev 2013 (S1)212; 52-53: P3.035. (Article publié).
  • The DECIDE Study Investigators. (2013). Physicians' and nurses' perceived barriers to end-of-life communication and decision-making with hospitalized medical Patients and their families: a multicentre, mixed methods study. Canadian Society of Internal Medicine Annual Scientific Meeting 2013. (Article publié).
  • Laflamme M, Boutin A, Haghbayan H, Shemilt M, Lauzier F, Moore L, Zarychanski R, Lacroix J, Lamontagne F, Fergusson DA, Desjardins P, Turgeon AF. (2013). Red Blood Cell Transfusion in Acute Cerebral Injuries: a Systematic Review of Preclinical Studies. Canadian Critical Care Forum 2013. (Article publié).
  • Lauzier F, Lachance O, Cote I, Senay B, Archambault P, Lamontagne F, Boutin A, Shemilt M, Moore L, Bernard F, Gagnon C, Cook D, Turgeon AF. (2013). Risk factors of Pituitary Disorders Following Traumatic Brain Injury. 33th International Symposium on Intensive Care and Emergency Medecine. Critical Care 2013; 17(Suppl2): P332. (Article publié).
  • Leblanc G, Boutin A, Lauzier F, Potvin V, Moore L, Zarychanski R, Archambault P, Lamontagne F, Turgeon AF. (2013). Withdrawal of life-sustaining therapies in severe traumatic brain injury. Canadian Anesthesiologist’s Society annual meeting. Canadian Anesthesiologist’s Society annual meeting. (Article publié).
  • Barwich D, You JJ, Heyland DK, Hanvey L, Baxter S, Dodek P, Lamontagne F, Tayler C, Porterfield P, Simon J, Enns B. (2012). Advance care planning and the ACCEPT Study: How are we doing and how can we improve?. the 19th International Congress on Palliative Care. (Article publié).
  • Heyland DK, Dodek P, Lamontagne F, You J, Barwich D, Tayler C, Porterfield P, Simon J, Enns B. (2012). Advance care planning evaluation in hospitalized elderly patients: A multicenter, prospective study (The ACCEPT Study). 3rd International Society of Advance Care Planning and End of Life Care Conference. (Article publié).
  • Simon J, Barwich D, Heyland D, You JJ, Tayler C, Dodek P, Lamontagne F, Porterfield P, Enns B. (2012). Advance care planning evaluation in hospitalized elderly patients: a multicenter, prospective study (The ACCEPT Study). Annual Canadian Society of Palliative Physicians Annual Meeting. (Article publié).
  • Simon J, Barwich D, Heyland D, You JJ, Tayler C, Dodek P, Lamontagne F, Porterfield P, Enns B. (2012). Advance care planning evaluation in hospitalized elderly patients: a multicenter, prospective study (The ACCEPT Study). Annual Canadian Society of Palliative Physicians Annual Meeting. (Article publié).
  • Lamontagne F, Adhikari N, Cook D, Koo KK, Lauzier F, Burns KE, Douglas I, Turgeon AF, Quiroz H, Poulin Y, Choong K, Ferguson N, Kho ME, Duffett M, Chant C, Lesur O, Meade MO. (2012). Corticosteroids for critically ill patients: an international survey of intensivists. 32nd International Symposium on Intensive Care and Emergency Médicine. Critical Care 2012; 16(Suppl1): P101. 101. (Article publié).
  • Zarychanski R, Lim W, Rocha M, McIntyre L, Lamontagne F, Dodek P, Pai M, Cooper DJ, Alhashemi J, Zytaruk N. (2012). Do Statins Influence DVT Risk in the Critically Ill Patients? (Research citation finalist). Society of Critical Care Medicine Congress 2012. (Article publié).
  • Granton J, Friedrich J, Fergusson N, Finfer S, Kutsogiannis J, Lesur O, Lamontagne F, Jacka M, Guyatt G, Lellouche F, Qushmaq I, Alhashemi I, Alsultan M, Sharpe M, Davies A, Sheppard J, Zytaruk N,. (2012). Heparin-Induced Thrombocytopenia In The ICU: ELISA Versus SRA Testing. American Thoracic Society International Conference (2012). Am J Resp Crit Care Med. 2012;185: A1669. (Article publié).
  • Leblanc G, Boutin A, Lauzier F, Potvin V, Moore L, Zarychanski R, Archambault P, Lamontagne F, Turgeon A. (2012). Incidence and impact of withdrawal of life-sustaining therapy in clinical trials of severe traumatic brain injury: a systematic review. Critical Care Canada Forum 2012. (Article publié).
  • Cameron JI, Chan L, Czerwonka AI, Chu LM, Matte AL, Ferguson ND, Mehta S, Friedrich J, Adhikari N, Fowler R, Cook DJ, Rudkowski JC, Meggison H, Abbey SE, Batt JA, dos Santos CC, Flannery J,et al. (2012). Long-Term Outcomes After Prolonged Mechanical Ventilation: Family Caregiver Outcomes From The Towards RECOVER Study. American Thoracic Society International Conference (2012). Am. J. Respir. Crit. Care Med. 2012;185: A1090. (Article publié).
  • Cameron J, Chan L, Czerwonka A, Chu L, Matte A, Tomlinson G, Ferguson ND, Mehta S, Friedrich J, Adhikari N, Fowler R, Lamontagne F, Rudkowski J, Meggison H, Ayas N, Skrobik Y, Batt J, et al. (2012). Long-Term Outcomes after Prolonged Mechanical Ventilation: Family Caregiver Outcomes from the Towards RECOVER Study. Critical Care Canada Forum 2012. (Article publié).
  • Herridge, Margaret; CHU, Leslie; Matte, Andrea; Chan, Linda; Tomlinson, George; Ferguson, Niall; Mehta, Sangeeta; Friedrich, Jan; Adhikari, Neill; Fowler, Robert; Rudkowski, Jill; et al. (2012). Long-Term Patient Outcomes After Prolonged Mechanical Ventilation: The Towards RECOVER Study. American Thoracic Society International Conference (2012). Am. J. Respir. Crit. Care Med. 2012;185: A2546. (Article publié).
  • Lamontagne F, Heels-Ansdell D, Mcintyre L, Dodek P, Meade M, Skrobik Y, McDonald E, Vallance S, Zytaruk N, Cook D. (2012). Non-Leg Venous Thrombi During Critical Illness: A Nested Prospect Cohort Study. Critical Care Medecine, U208-209. (Article publié).
  • You JJ, Heyland DK, Dodek P, Lamontagne F, Barwich D, Tayler C, Porerfield P, Simon J, Enns B. (2012). Opportunities to improve end-of-life communication and decision-making for seriously ill hospitalized patients and their families. 3rd International Society of Advance Care Planning and End of Life Care Conference. (Article publié).
  • Laroche E, Turgeon AF, Boutin A, Mercier E, Lauzier F, Zarychanski R, Moore L, Granton J, Archambault P, Lamontagne F, Rousseau F, Légaré F, Randell E, Lapointe J, Lacroix J, Fergusson D. (2012). Predictive value of glial fibrillary acidic protein for prognosis in patients with moderate and severe traumatic brain injury: a systematic review and meta-analysis. 32th International Symposium on Intensive Care and Emergency Médicine. Critical Care 2012; 16(Suppl1): P298. (Article publié).
  • Mercier E, Turgeon AF, Boutin A, Lauzier F, Zarychanski R, Archambault P, Granton J, Lamontagne F, Moore L, Roussea F, Légaré F, Randell E, Lacroix J, Lapointe J, Fergusson D. (2012). Predictive value of neuron-specific enolase following moderate and severe traumatic brain injury: a systematic review and meta-analysis. 32th International Symposium on Intensive Care and Emergency Médicine. Critical Care 2012; 16(Suppl1): P311. (Article publié).
  • Lauzier F, Lachance O, Senay B, Côté I, Archambault P, Lamontagne F, Boutin A, Moore L, Bernard F, Gagnon C, Cook D, Turgeon AF. (2012). Prevalence of Pituitary Disorders associated with Traumatic Brain Injury: a systematic review. 32th International Symposium on Intensive Care and Emergency Médicine. Critical Care 2012; 16(Suppl1): P299. (Article publié).
  • Zytaruk N, Meade M, Mehta S, Hall R, Granton J, Ferguson ND, Freitag A, Muscedere J, Fowler R, Skrobik Y, Jacka M, Marshall J, Lauzier F, Lamontagne F, et al. (2012). Risk Factors For Pulmonary Embolism In Medical-Surgical ICU Patients. American Thoracic Society meeting 2012. Am J Resp Crit Care Med. 2012;185: A2359. (Article publié).
  • Lalu MM, McIntyre L, Lamontagne F, Bains J, Mei SHJ, Fergusson D, Winston BW, Marshall JC, Walley KR, Courtman D, Stewart DJ. (2012). Systematic review and meta-analysis of mesenchymal stromal cells in pre-clinical models of septic shock. Am J Resp Crit Care Med 2012, 185:A2215. (Article publié).
  • D'Aragon F*, Belley-Côté É*, Lauzier F, Briel M, Cook D, Meade M, Fox-Robichaud A, Duffett M, Kanji S, Lamontagne F. (2012). Systematic review of pre-clinical studies comparing different vasopressor dosing strategies. American Thoracic Society International Conference (2012). Am J Respir Crit Care Med. 2012;185: A5998. (Article publié).
  • D'Aragon F*, Belley-Côté É*, Lamontagne F. (2012). Systematic review of pre-clinical studies comparing different vasopressor dosing strategies. Canadian Anesthesiologist’s Society. (Article publié).
  • Heyland DK, Dodek P, Lamontagne F, You J, Barwich D, Tayler C, Porterfield P, Simon J, Enns B. (2012). The development and validation of a questionnaire to audit advance care planning (ACP). 3rd International Advance Care Planning and End of Life Care Conference 2012. (Article publié).
  • Crowther MA, Heels-Ansdell D, Williamson D, Granton J, Burry L, Lamontagne F, Finfer S, McDonald E, Vallance S, Klinger J, Friedrich J, Paunovic B, Walter S, Zytaruk N, Cook DJ, Warkentin TE. (2011). 4Ts HIT Scoring in the Medical-Surgical ICU. Amer Soc Hematology 2011. (Article publié).
  • Ribic CM, Lamontagne F, Johnston BC, Briel M, You J, Sun X, Busse JW, Basler D, Vera C, Al-Shurafa M, Mills EJ, Guyatt GH, Cook DJ, Akl EA. (2011). Concordance of reporting of primary outcomes in abstracts versus full text of randomized control trials: is there an outcome reporting bias?. 19th Cochrane Colloquium. Cochrane Database Syst Rev 2011 (S3)233; 141: A P2.B256. (Article publié).
  • Masse V*, Yale P*, Meade M, Fowler R, Adhikari N, Henzler D, Christian M, Herridge M, Lamontagne F. (2011). Corticosteroid Use In a Cohort Of ICU Patients Infected With Influenza. Am J Resp Crit Care Med 2011, 183:A1657. (Article publié).
  • Delaney JW, Lamontagne F, Marshall J, Long J, Kumar A, Hutchison J, Jouvet P, Menon K, Fowler RA, on behalf of the ICU-Flu investigators. (2011). Corticosteroids In The Treatment of Influenza A 2009 (H1N1)-Associated Critical Illness. American Thoracic Society International Conference (2011). (Article publié).
  • Delaney JW, Lamontagne F, Marshall J, Long J, Kumar A, Hutchison J, Jouvet P, Menon K, Fowler RA. (2011). Corticosteroids In The Treatment of Influenza A 2009 (H1N1)-Associated Critical Illness. Am J Resp Crit Care Med 2011, 183:A3139. (Article publié).
  • Lamontagne F, Ferguson ND, Adhikari N, Cook D, Hand L, Henzler D, Zhou Q, Meade M. Corticosteroid use in ARDS patients enrolled in the Oscillation for ARDS Treated Early (OSCILLATE) Trial. (2011). Corticosteroid use in ARDS patients enrolled in the Oscillation for ARDS Treated Early (OSCILLATE) Trial. American Thoracic Society International Conference (2011). (Article publié).
  • Alshurafa M, Guyatt GH, Akl EA, Haines T, Gentles S, Rios L, Tran C, Lamontagne F, Moayyedi P, Walter SD, Briel B. (2011). Definitions of intention-to-treat in the face of missing outcome data: a systematic survey of methodology papers. 19th Cochrane Colloquium. Cochrane Database Syst Rev 2011 (S3)233; 124: A P2.B212. (Article publié).
  • Hand L, Adhikari N, Cook DJ, Mehta S, Matte AL, McArdle T, Clarke F, Lamontagne F, Meade M, Ferguson N. (2011). Initial Ventilatory Parameters For High Frequency Oscillation In A Pilot RCT Compared With Recent Historical Controls. Am J Resp Crit Care Med 2011, 183:A1685. (Article publié).
  • Hand L, Adhlkari N, Cook D, Mehta S, matte A, McArdle T, Clarke F, Lamontagne F, Meade MO, Ferguson N. (2011). Initial ventilator parameters for high frequency oscillation in a RCT compared with recent historical controls – AH (Allied Health). Critical Care Canada Forum 2011. (Article publié).
  • Cameron JI, Chan L, Czerwonka A, Chu LM, Matte A, Ferguson ND, Mehta S, Friedrich J, Adhikari N, Fowler R, Cook D, Rudkowski J, Meggison H, Abbey SE, Batt JA, dos Santos CC, Flannery JF, et al. (2011). Long-Term Outcomes after Prolonged Mechanical Ventilation: Family Caregiver Outcomes from the Towards RECOVER Study. Critical Care Canada Forum 2011. (Article publié).
  • Herridge MS, Chu LM, Matte AL, Chan L, Tomlinson G, Ferguson ND, Mehta S, Friedrich J, Adhikari N , Fowler R, Cook D, Rudkowski J, Meggison H, Abbey SE, Batt JA, dos Santos CC, Flannery JF, Leung G, Marshall JC, Rubenfeld G, Scales DC, Sinuff T, Slutsky AS, Lamontagne F, Cameron JI. (2011). Long-Term Patient Outcomes After Prolonged Mechanical Ventilation: The Towards RECOVER Study. Critical Care Canada Forum 2011. (Article publié).
  • St-Arnaud C*, Éthier JF, Leclair MA, Lamontagne F. (2011). Prescribed targets for vasopressor titration in septic shock: a retrospective cohort study. European society of intensive care medicine 24th annual congress. . Intensive care medicine. 2011;37(S1): S231:A0904. (Article publié).
  • Heels-Ansdell D, Zytaruk N, Meade M, Mehta S, Hall R, Zarychanski R, Rocha M, Lim W, Lamontagne F, McIntyre L, Dodek P, Vallance S, Davies A, Cooper J, Cook D. (2011). Pulmonary embolism in medical-surgical patients. 31st International Symposium on Intensive Care and Emergency Medicine. (Article publié).
  • Duffett M, Burns K, Adhikari N, Arnold D, Lauzier F, Kho ME, Meade M, Hayani O, Koo K, Choong K, Cupido C, Lamontagne F, Cook D. (2011). Quality Of Reporting Of surveys In Critical Care Journals: A Methodologic Review. Am J Resp Crit Care Med 2011, (Article publié).
  • Zytaruk N, Lamontagne F, McIntyre L, Dodek D, Vlahakis N, Lewis B, Schiff D, MoodyA, Ostermann M, Padayachee S, Heels-Ansdell D, Vallance S, Davies A, Cooper DJ, Cook DJ. (2011). Upper Extremity Thromboses in Medical-Surgical Critically Ill Patients. 31st International Symposium on Intensive Care and Emergency Medicine. (Article publié).
  • Delaney J, Fowler R, Long J, Lamontagne F, Marshall J, Kumar A, Cook D, Hutchison J, Jouvet P. (2010). Corticosteroids in the treatment of Influenza A 2009 (H1N1) - associated critical illness. Critical Care Canada Forum 2010. (Article publié).
  • Briel MB, Meade MO, Mercat A, Brower RG, Talmor D, Slutsky AS, Cook DJ, Brochard L, Richard JC, Lamontagne F, Stewart T, Guyatt GH. (2010). Higher versus lower positive end-expiratory pressure in acute lung injury and acute respiratory distress syndrome: systematic review and individual patient data meta-analysis. 30st International Symposium on Intensive Care and Emergency Medicine. (Article publié).
  • Akl EA, Briel M, Sun X, Busse J, You J, Bradley J, Mulla SM, Lamontagne F, Bassler D, Vera C, Alshurafa SM, Katsios CM, Mills E, Walter SD, Cook D, Schunemann H, Altman D, Guyatt G. (2010). LOST to follow-up information in trials (LOST-IT): the potential impact on the estimates of treatment effect. 2010 Joint Colloquium of the Cochrane & Campbell collaborations. (Article publié).
  • Lamontagne F, Briel M, Duffett M, Fox-Robichaud A, Cook DJ, Guyatt G, Meade MO for the ACCADEMY. (2010). Systematic review of reviews of preclinical studies on therapeutic interventions for sepsis. Am J Resp Crit Care Med 2010, 181:A5802. (Article publié).
  • Akl EA, Sun X, Busse J, Johnston B, Briel M, Mulla S, You J, Bassler D, Lamontagne F, Vera C, Alshurafa M, Katsios C, Mills E, Guyatt G. (2010). The reliability and validity of estimating unclearly reported blinding status in randomized clinical trials. 2010 Joint Colloquium of the Cochrane & Campbell collaborations. (Article publié).
  • Lamontagne F, Briel M, Duffett M, Kho M, Burns KE, Adhikari N, Turgeon AF, Guyatt G, Zhou Q, Cook D, Meade M for the ACCADEMY and the Canadian Critical Care Trials Group. (2010). Vasopressor Administration: A Survey of Canadian Intensivists. Am J Resp Crit Care Med 2010., 181: A4543. (Article publié).
  • Lamontagne F, Tremblay A, Plante GE, Lesur O. (2004). Impact d’un IECA sur l’activité des polynucléaires neutrophiles dans un modèle murin endotoxinique. 2004 Annual meeting of the Société Française de Réanimation de Langue Française. (Article publié).
  • Lamontagne F, Lalancette M, Martinet O, Pépin J, Lesur O. (2004). difficileÉpidémie de formes sévères de Colite à Clostridium au Québec : résultats préliminaires au CHU de Sherbrooke. 2004 Annual meeting of the Société Française de Réanimation de Langue Française. (Article publié).
  • Lamontagne F, Chainey A, Lesur O, Plante GE. (2003). Activation des neutrophiles et choc septique. Annual meeting of the Club de recherche clinique du Québec (CRCQ). (Article publié).

Autres contributions

Activités de collaboration internationale

  • Co-investigator. (2009-2015). Canada.
  • Co-investigator. (2009-2015). Canada.
  • Steering committee. (2008-2013). Canada.
  • Co-investigator. (2007-2011). Canada.
  • Principal investigator. (2015). Royaume-Uni.
  • Co-investigator. (2009). Suisse.
  • Co-investigator. (2007). Canada.

Présentations

  • (2020). An Update in blood pressure targets and vasopressor therapy. Critical Care Canada Forum. Web conference, Canada.
  • (2020). COVID-19 Approach Management. Critical Care Canada Forum. Web conference, Canada.
  • (2020). COVIDB: une base de données multimédia des patients avec COVID-19 suspecté ou confirmé. ASMIQ Symposium. Canada.
  • (2020). Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients with Vasodilatory Hypotension: A Randomized Clinical Trial. Critical Care Canada Forum. Web conference, Canada.
  • (2020). Exposure to vasopresssors in older critically ill patients. 25th Brazilian Congress of Intensive Care Medicine. virtual, Brésil.
  • (2020). LOVIT. Canadian Critical Care Trials Group (CCCTG) Winter 2020. Sherbrooke, Canada.
  • (2020). OVATION 65. Canadian Critical Care Trials Group (CCCTG) Winter 2020. Lake Louise, Canada.
  • Alison Fox-Robichaud. (2020). Sepsis Canada Network (SCN) (SepsisCAN) - Sepsis: Before During and After. Canadian Critical Care Trials Group (CCCTG) Winter 2020. Lake Louise, Canada.
  • (2019). Global collaboration: easy to say, hard to do. InFACT - Global collaboration in clinical trials, World Congress of Intensive Care. Melbourne, Australie.
  • (2019). Lessening Organ Dysfunction with VITamin C: The LOVIT Trial. Critical Care Medicine Grand Rounds: Queen's University and Kingston Health Sciences Centre. Kingston, Canada.
  • (2017). Guidelines and policies on how to respond to a crisis. Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R) General Assembly. Seoul, Corée, République de.
  • (2017). Impact of Vasopressors. Critical care Canada Forum. Toronto, Canada.
  • (2017). Ovation 65. CMP Annual Conference. London, Royaume-Uni.
  • (2017). Pooled analysis of higher vs lower blood pressure targets for vasopressors. 30th Annual Congress of Intensive Care Medicine (ESICM LIVES 2017). Autriche.
  • (2017). Standard vs. Accelerated Renal Replacement Therapy in Critically Ill Patients with Acute Kidney Injury (STARRT-AKI). Réanimation 2017, Annual Congress of the Société de reanimation de langue française (SRLF). France.
  • Ellen McDonald. (2016). Benchmarking and facilitating CCCTG productivity. Canadian Critical Care Trials Group Spring 2016 Meeting. Halifax, Canada.
  • (2016). Collaboration multidisciplinaire, recherche et sécurité des soins. Le programme ovation. Mouvement en Recherche Clinique et Épidémiologique. Centre de recherche du CHUS. Sherbrooke, Canada.
  • (2016). Collaboration multidisciplinaire, recherche et sécurité des soins – Le programme OVATION et vasopresseurs. Congrès intensif 2016. Regroupement des infirmières et infirmiers en soins intensifs du Québec. Boucherville, Canada.
  • (2016). Guidelines and Recommendations – Knowledge Translation Proposal. Canadian Critical Care Trials Group Spring 2016 Meeting. Halifax, Canada.
  • (2016). OVATION Program: progress, end-of-grant KT and translational substudy. Canadian Critical Care Trials Group Spring 2016 Meeting. Halifax, Canada.
  • (2016). Patient Quality of Life Post-ICU Discharge Following Prolonged Mechanical Ventilation. Canadian Association of Critical Care Nurses. The Quarterly Workshop: Looking Beyond the ICU. Montreal, Canada.
  • Paul Mouncey. (2016). Plenary presentation - New Trials / New Directions: The 65 Trial. ICS State of the Art Meeting 2016. London, Royaume-Uni.
  • (2016). The potential benefit of vasopressor stewardship – Insights from the OVATION program. University of Toronto Critical Care Physiology Rounds Committee. Toronto, Canada.
  • (2015). Connaissez-vous bien la réalité des soins intensifs en 2015?. Conference of the Centre de recherche du CHUS. Sherbrooke, Canada.
  • (2015). Quand la vie est un enjeu. Une séance de sensibilisation publique offerte par l'Unité des soins intensifs du CHUS. Sherbrooke, Canada.
  • (2014). Blood Pressure Targets - Too High or Too Low?. CCCTG Fall 2014 Scientific Meeting. Toronto, Canada.
  • (2014). Facteurs déterminant le recours aux corticostéroïdes et syndrome de détresse respiratoire Aigu. Congrès Annuel de la Société des Intensivistes du Québec. Québec, Canada.
  • (2014). La recherche aux soins intensifs. Présentation clinico-académique du centre hospitalier universitaire de Sherbrooke. Sherbrooke, Canada.
  • (2014). Missions en Guinée et au Libéria contre Ébola. Midi rencontre of the FMSS. Sherbrooke, Canada.
  • (2013). Essai clinique - Oscillation for ARDS treated early (étude OSCILLATE). 40e congrès de l'Ordre professionnel des inhalothérapeutes du Québec. Montréal, Canada.
  • (2011). Determinants of practice variation in corticosteroid administration for ARDS. Toronto Critical Care Medicine Symposium / Critical Care Canada Forum presentation. Toronto, Canada.